10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2022

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For the transition period from _____to _____

Commission File Number 001-36801

Qorvo, Inc.

(Exact name of registrant as specified in its charter) 

Delaware		46-5288992
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
7628 Thorndike Road
Greensboro,	North Carolina	27409-9421
(Address of principal executive offices)		(Zip code)

(336) 664-1233

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.0001 par value	QRVO	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	þ	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No þ

As of January 26, 2023, there were 99,889,210 shares of the registrant’s common stock outstanding.

QORVO, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

	Page
PART I — FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited).
Condensed Consolidated Balance Sheets	3
Condensed Consolidated Statements of Operations	4
Condensed Consolidated Statements of Comprehensive Income	5
Condensed Consolidated Statements of Stockholders' Equity	6
Condensed Consolidated Statements of Cash Flows	8
Notes to Condensed Consolidated Financial Statements	9
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.	19
Item 3. Quantitative and Qualitative Disclosures About Market Risk.	29
Item 4. Controls and Procedures.	29
PART II — OTHER INFORMATION	30
Item 1A. Risk Factors.	30
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.	30
Item 5. Other Information.	31
Item 6. Exhibits.	32
SIGNATURES	33

2

PART I — FINANCIAL INFORMATION

ITEM 1.

QORVO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

(Unaudited)

 

	December 31, 2022		April 2, 2022
ASSETS
Current assets:
Cash and cash equivalents	$	918,758	$	972,592
Accounts receivable, net of allowance of $405 and $402 as of December 31, 2022 and April 2, 2022, respectively	367,636		568,850
Inventories	857,277		755,748
Prepaid expenses	46,105		49,839
Other receivables	30,832		32,151
Other current assets	37,092		70,685
Total current assets	2,257,700		2,449,865
Property and equipment, net of accumulated depreciation of $1,846,373 and $1,734,608 as of December 31, 2022 and April 2, 2022, respectively	1,191,986		1,253,591
Goodwill	2,770,146		2,775,634
Intangible assets, net	567,375		674,786
Long-term investments	24,218		31,086
Other non-current assets	264,794		324,110
Total assets	$	7,076,219	$	7,509,072
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	225,111	$	327,915
Accrued liabilities	239,013		240,186
Other current liabilities	149,466		107,026
Total current liabilities	613,590		675,127
Long-term debt	2,047,743		2,047,098
Other long-term liabilities	250,318		233,629
Total liabilities	2,911,651		2,955,854
Commitments and contingent liabilities (Note 8)
Stockholders’ equity:
Preferred stock, $.0001 par value; 5,000 shares authorized; no shares issued and outstanding	—		—
Common stock and additional paid-in capital, $.0001 par value; 405,000 shares authorized; 100,021 and 106,303 shares issued and outstanding at December 31, 2022 and April 2, 2022, respectively	3,859,940		4,035,849
Accumulated other comprehensive (loss) income	(11,365)		5,232
Retained earnings	315,993		512,137
Total stockholders’ equity	4,164,568		4,553,218
Total liabilities and stockholders’ equity	$	7,076,219	$	7,509,072

See accompanying Notes to Condensed Consolidated Financial Statements.

3

 QORVO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

	Three Months Ended				Nine Months Ended
	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Revenue	$	743,281	$	1,113,957	$	2,936,696	$	3,479,556
Cost of goods sold	475,230		565,864		1,754,468		1,763,727
Gross profit	268,051		548,093		1,182,228		1,715,829
Operating expenses:
Research and development	149,472		154,435		486,204		464,891
Selling, general and administrative	76,269		82,003		275,836		265,791
Other operating expense	33,581		15,645		48,038		29,675
Total operating expenses	259,322		252,083		810,078		760,357
Operating income	8,729		296,010		372,150		955,472
Interest expense	(17,066)		(15,328)		(51,222)		(45,934)
Other income, net	5,562		2,532		2,714		24,077
(Loss) income before income taxes	(2,775)		283,214		323,642		933,615
Income tax expense	(13,156)		(66,951)		(82,074)		(112,537)
Net (loss) income	$	(15,931)	$	216,263	$	241,568	$	821,078
Net (loss) income per share:
Basic	$	(0.16)	$	1.97	$	2.34	$	7.40
Diluted	$	(0.16)	$	1.95	$	2.33	$	7.30
Weighted average shares of common stock outstanding:
Basic	100,943		109,687		103,039		110,966
Diluted	100,943		110,810		103,812		112,415

See accompanying Notes to Condensed Consolidated Financial Statements.

4

QORVO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

(Unaudited)

	Three Months Ended				Nine Months Ended
	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Net (loss) income	$	(15,931)	$	216,263	$	241,568	$	821,078
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment, including intra-entity foreign currency transactions that are of a long-term investment nature	30,403		(8,488)		(16,623)		(14,767)
Reclassification adjustments, net of tax:
Foreign currency gain realized upon liquidation of subsidiary	—		(359)		—		(359)
Amortization of pension actuarial loss	8		29		26		90
Other comprehensive income (loss)	30,411		(8,818)		(16,597)		(15,036)
Total comprehensive income	$	14,480	$	207,445	$	224,971	$	806,042

                

See accompanying Notes to Condensed Consolidated Financial Statements.

5

QORVO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(In thousands)

(Unaudited)

				Accumulated Other Comprehensive (Loss) Income		Retained Earnings
	Common Stock
Three Months Ended	Shares	Amount						Total
Balance, October 1, 2022	102,061	$	3,915,969	$	(41,776)	$	447,947	$	4,322,140
Net loss	—	—		—		(15,931)		(15,931)
Other comprehensive income	—	—		30,411		—		30,411
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	41	(321)		—		—		(321)
Issuance of common stock in connection with employee stock purchase plan	150	11,276		—		—		11,276
Repurchase of common stock, including transaction costs	(2,231)	(85,610)		—		(116,023)		(201,633)
Stock-based compensation	—	18,626		—		—		18,626
Balance, December 31, 2022	100,021	$	3,859,940	$	(11,365)	$	315,993	$	4,164,568
Balance, October 2, 2021	110,461	$	4,158,170	$	23,431	$	546,153	$	4,727,754
Net income	—	—		—		216,263		216,263
Other comprehensive loss	—	—		(8,818)		—		(8,818)
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	41	(527)		—		—		(527)
Issuance of common stock in connection with employee stock purchase plan	108	15,503		—		—		15,503
Repurchase of common stock, including transaction costs	(1,942)	(73,092)		—		(228,928)		(302,020)
Stock-based compensation	—	19,044		—		—		19,044
Balance, January 1, 2022	108,668	$	4,119,098	$	14,613	$	533,488	$	4,667,199

See accompanying Notes to Condensed Consolidated Financial Statements.

6

QORVO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(In thousands)

(Unaudited)

				Accumulated Other Comprehensive (Loss) Income		Retained Earnings
	Common Stock
Nine Months Ended	Shares	Amount						Total
Balance, April 2, 2022	106,303	$	4,035,849	$	5,232	$	512,137	$	4,553,218
Net income	—	—		—		241,568		241,568
Other comprehensive loss	—	—		(16,597)		—		(16,597)
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	550	(21,502)		—		—		(21,502)
Issuance of common stock in connection with employee stock purchase plan	345	30,169		—		—		30,169
Repurchase of common stock, including transaction costs	(7,177)	(274,020)		—		(437,712)		(711,732)
Stock-based compensation	—	89,444		—		—		89,444
Balance, December 31, 2022	100,021	$	3,859,940	$	(11,365)	$	315,993	$	4,164,568
Balance, April 3, 2021	112,557	$	4,244,740	$	29,649	$	355,036	$	4,629,425
Net income	—	—		—		821,078		821,078
Other comprehensive loss	—	—		(15,036)		—		(15,036)
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	683	(49,979)		—		—		(49,979)
Issuance of common stock in connection with employee stock purchase plan	273	33,297		—		—		33,297
Repurchase of common stock, including transaction costs	(4,845)	(182,767)		—		(642,626)		(825,393)
Stock-based compensation	—	73,807		—		—		73,807
Balance, January 1, 2022	108,668	$	4,119,098	$	14,613	$	533,488	$	4,667,199

See accompanying Notes to Condensed Consolidated Financial Statements.

7

QORVO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Nine Months Ended
	December 31, 2022		January 1, 2022
Cash flows from operating activities:
Net income	$	241,568	$	821,078
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	155,132		159,038
Intangible assets amortization	99,476		112,523
Deferred income taxes	(2,557)		37,566
Stock-based compensation expense	86,911		73,236
Other, net	95,459		6,703
Changes in operating assets and liabilities:
Accounts receivable, net	201,823		(170,511)
Inventories	(98,882)		(190,247)
Prepaid expenses and other assets	42,979		(145,643)
Accounts payable and accrued liabilities	(85,321)		42,797
Income taxes payable and receivable	(17,281)		(16,303)
Other liabilities	58,481		(26,874)
Net cash provided by operating activities	777,788		703,363
Cash flows from investing activities:
Purchase of property and equipment	(124,853)		(162,993)
Purchase of businesses, net of cash acquired	(95)		(389,192)
Other investing activities	7,590		9
Net cash used in investing activities	(117,358)		(552,176)
Cash flows from financing activities:
Payment of debt	—		(197,500)
Proceeds from debt issuances	—		499,070
Repurchase of common stock, including transaction costs	(711,732)		(825,393)
Proceeds from the issuance of common stock	20,828		26,653
Tax withholding paid on behalf of employees for restricted stock units	(22,687)		(52,265)
Other financing activities	(422)		(9,078)
Net cash used in financing activities	(714,013)		(558,513)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(280)		(2,063)
Net decrease in cash, cash equivalents and restricted cash	(53,863)		(409,389)
Cash, cash equivalents and restricted cash at the beginning of the period	972,805		1,398,309
Cash, cash equivalents and restricted cash at the end of the period	$	918,942	$	988,920
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	$	918,758	$	988,527
Restricted cash included in "Other current assets" and "Other non-current assets"	184		393
Total cash, cash equivalents and restricted cash	$	918,942	$	988,920
Supplemental disclosure of cash flow information:
Capital expenditures included in liabilities	$	26,597	$	42,055

See accompanying Notes to Condensed Consolidated Financial Statements.

8

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

The accompanying Condensed Consolidated Financial Statements of Qorvo, Inc. and Subsidiaries (together, the "Company" or "Qorvo") have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP"). The preparation of these financial statements requires management to make estimates and assumptions, which could differ materially from actual results. In addition, certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). In the opinion of management, the financial statements include all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of the interim periods presented. These Condensed Consolidated Financial Statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto included in Qorvo’s Annual Report on Form 10-K for the fiscal year ended April 2, 2022.

The Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. During the second quarter of fiscal 2023, the Company updated its organizational structure to more closely align similar technologies and applications with customers and end markets. The Company manages its business and reports its financial results in three reportable segments: High Performance Analog ("HPA"), Connectivity and Sensors Group ("CSG") and Advanced Cellular Group ("ACG").

Certain items in the fiscal 2022 financial statements (including prior period segment results) have been reclassified to conform with the fiscal 2023 presentation.

The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. Each fiscal year, the first quarter ends on the Saturday closest to June 30, the second quarter ends on the Saturday closest to September 30 and the third quarter ends on the Saturday closest to December 31. Fiscal years 2023 and 2022 are 52-week years.

2. INVENTORIES

The components of inventories, net of reserves, are as follows (in thousands):

	December 31, 2022		April 2, 2022
Raw materials	$	318,288	$	236,095
Work in process	350,122		357,332
Finished goods	188,867		162,321
Total inventories	$	857,277	$	755,748

3. BUSINESS ACQUISITIONS

United Silicon Carbide, Inc.

On October 19, 2021, the Company acquired all the outstanding equity interests of United Silicon Carbide, Inc. ("United SiC"), a leading manufacturer of silicon carbide ("SiC") power semiconductors, for a total purchase price of $236.7 million. The acquisition expanded the Company's offerings to include SiC power products for a range of applications, such as electric vehicles, battery charging, IT infrastructure, renewables and circuit protection.

The purchase price comprised cash consideration of $227.2 million and contingent consideration of up to $31.3 million which is expected to be paid to the sellers (in the first quarter of fiscal 2024) upon achieving certain revenue and gross margin targets over the period beginning on the acquisition date through December 31, 2022. The estimated fair value of the contingent consideration liability was $9.5 million as of the acquisition date. At April 2, 2022, the contingent consideration liability was remeasured to a fair value of $17.6 million and is included in "Other long-term liabilities" in the Condensed Consolidated Balance Sheet. At December 31, 2022, the maximum contingent consideration of $31.3 million was earned and is included in "Other current liabilities" in the Condensed Consolidated Balance Sheet, with the increase in fair value recognized in "Other operating expense" in the Condensed Consolidated Statement of Operations. Refer to Note 5 for further information related to the fair value measurement.

9

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

NextInput, Inc.

On April 5, 2021, the Company acquired all the outstanding equity interests of NextInput, Inc. ("NextInput"), a leader in microelectromechanical system ("MEMS")-based sensing solutions, for a total cash purchase price of $173.3 million. The acquisition expanded the Company's offerings of MEMS-based products for mobile applications, providing sensing solutions for a broad range of applications in other markets.

4. GOODWILL AND INTANGIBLE ASSETS

During the second quarter of fiscal 2023, the Company updated its organizational structure (see Note 1).

The changes in the carrying amount of goodwill are as follows (in thousands):

	HPA		CSG		ACG		Total
Balance as of April 2, 2022 (1)	$	501,899	$	539,875	$	1,733,860	$	2,775,634
NextInput measurement period adjustments	—		572		—		572
United SiC measurement period adjustments	(297)		—		—		(297)
Effect of changes in foreign currency exchange rates	—		(5,763)		—		(5,763)
Balance as of December 31, 2022 (1)	$	501,602	$	534,684	$	1,733,860	$	2,770,146

(1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs totaling $669.6 million, which were recognized in fiscal years 2009, 2013, 2014 and 2022.

The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands):

	December 31, 2022				April 2, 2022
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Developed technology	$	866,916	$	352,141	$	1,026,690	$	420,255
Customer relationships	104,429		62,703		104,778		47,208
Technology licenses	1,411		405		2,641		2,169
Trade names	899		664		1,933		1,358
In-process research and development	9,633		N/A		9,734		N/A
Total (1)	$	983,288	$	415,913	$	1,145,776	$	470,990

(1) Amounts include the impact of foreign currency translation.

At the beginning of each fiscal year, the Company removes the gross asset and accumulated amortization amounts of intangible assets that have reached the end of their useful lives and have been fully amortized. Useful lives are estimated based on the expected economic benefit to be derived from the intangible assets.

5. INVESTMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS

Equity Method Investments

The Company invests in limited partnerships and accounts for these investments using the equity method. The carrying amounts of these investments, as of December 31, 2022 and April 2, 2022, were $20.2 million and $27.1 million, respectively, and are classified as "Long-term investments" in the Condensed Consolidated Balance Sheets. During the three and nine months ended December 31, 2022, the Company recorded a loss of $5.0 million and $4.7 million, respectively, based on its share of the limited partnerships' earnings. During the three and nine months ended January 1, 2022, the Company recorded a loss of $2.4 million and income of $13.6 million, respectively, based on its share of the limited partnerships' earnings. These amounts are included in "Other income, net" in the Condensed Consolidated Statements of Operations. During the three and

10

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

nine months ended December 31, 2022, the Company received cash distributions of $0.2 million and $2.2 million, respectively, from these limited partnerships. No cash distributions were received during the three months ended January 1, 2022 and $13.5 million of cash distributions were received during the nine months ended January 1, 2022. The cash distributions were recognized as reductions to the carrying value of the investments and included in the cash flows from investing activities in the Condensed Consolidated Statements of Cash Flows.

Fair Value of Financial Instruments

The fair value of the financial assets and liabilities measured on a recurring basis was determined using the following levels of inputs (in thousands):

	Total		Quoted Prices In Active Markets For Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
December 31, 2022
Marketable equity securities	$	1,121	$	1,121	$	—	$	—
Invested funds in deferred compensation plan (1)	37,687		37,687		—		—
Contingent earn-out liability (2)	(31,250)		—		—		(31,250)
April 2, 2022
Marketable equity securities	$	2,906	$	2,906	$	—	$	—
Invested funds in deferred compensation plan (1)	39,356		39,356		—		—
Contingent earn-out liability (2)	(17,600)		—		—		(17,600)

(1) Invested funds under the Company's non-qualified deferred compensation plan are held in a rabbi trust and consist of mutual funds. The fair value of the mutual funds is calculated using the net asset value per share determined by quoted active market prices of the underlying investments.

(2) At December 31, 2022, the maximum contingent consideration was recorded related to the acquisition of United SiC (refer to Note 3). At April 2, 2022, the fair value of this liability was estimated using an option pricing model.

6. LONG-TERM DEBT

Long-term debt is as follows (in thousands):

	December 31, 2022		April 2, 2022
1.750% senior notes due 2024	$	500,000	$	500,000
4.375% senior notes due 2029	850,000		850,000
3.375% senior notes due 2031	700,000		700,000
Finance leases and other	1,839		2,581
Unamortized premium, discount and issuance costs, net	(3,645)		(4,692)
Less current portion of long-term debt	(451)		(791)
Total long-term debt	$	2,047,743	$	2,047,098

Credit Agreement

On September 29, 2020, the Company and certain of its U.S. subsidiaries (the "Guarantors") entered into a five-year unsecured senior credit facility pursuant to a credit agreement (as amended, restated, modified or otherwise supplemented from time to time, the "Credit Agreement") with Bank of America, N.A., acting as administrative agent, and a syndicate of lenders. The Credit Agreement amended and restated the previous credit agreement dated as of December 5, 2017. The Credit Agreement includes a senior revolving line of credit (the "Revolving Facility") of up to $300.0 million, and included a senior term loan of $200.0 million (collectively, the "Credit Facility"), that was fully repaid in fiscal 2022.

11

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

On April 6, 2022, the Company and the administrative agent entered into an amendment to the Credit Agreement (the "LIBOR Transition Amendment") to replace the London Interbank Offered Rate as a reference rate available for use in the computation of interest under the Credit Agreement. As a result of the LIBOR Transition Amendment, at the Company’s option, loans under the Credit Agreement will bear interest at (i) the Applicable Rate (as defined in the Credit Agreement) plus the Term SOFR (as defined in the Credit Agreement) or (ii) the Applicable Rate plus a rate equal to the highest of (a) the federal funds rate plus 0.50%, (b) the prime rate as set by the administrative agent, and (c) the Term SOFR plus 1.0% (the "Base Rate"). All swing line loans will bear interest at a rate equal to the Applicable Rate plus the Base Rate. The Term SOFR is the rate per annum equal to the forward-looking Secured Overnight Financing Rate term rate for interest periods of one, three or six months (as selected by the Company) plus an adjustment (as defined in the Credit Agreement). The Applicable Rate for Term SOFR loans ranges from 1.000% per annum to 1.250% per annum, and the Applicable Rate for Base Rate loans ranges from 0.000% per annum to 0.250% per annum. Undrawn amounts under the Credit Facility are subject to a commitment fee ranging from 0.150% to 0.200%.

During the three and nine months ended December 31, 2022, there were no borrowings under the Revolving Facility.

Senior Notes due 2024

On December 14, 2021, the Company issued $500.0 million aggregate principal amount of its 1.750% senior notes due 2024 (the "2024 Notes"). The 2024 Notes will mature on December 15, 2024, unless earlier redeemed in accordance with their terms. The 2024 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

The 2024 Notes were issued pursuant to an indenture, dated as of December 14, 2021 (the "2021 Indenture"), by and among the Company, the Guarantors and Computershare Trust Company, N.A., as trustee. The 2021 Indenture contains customary events of default, including payment default, exchange default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events. The 2021 Indenture also contains customary negative covenants.

Interest is payable on the 2024 Notes on June 15 and December 15 of each year. The Company paid interest of $4.4 million and $8.8 million on the 2024 Notes during the three and nine months ended December 31, 2022, respectively.

Senior Notes due 2029

On September 30, 2019, the Company issued $350.0 million aggregate principal amount of its 4.375% senior notes due 2029 (the "Initial 2029 Notes"). On December 20, 2019, and June 11, 2020, the Company issued an additional $200.0 million and $300.0 million, respectively, aggregate principal amount of such notes (together, the "Additional 2029 Notes" and together with the Initial 2029 Notes, the "2029 Notes"). The 2029 Notes will mature on October 15, 2029, unless earlier redeemed in accordance with their terms. The 2029 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

The Initial 2029 Notes were issued pursuant to an indenture, dated as of September 30, 2019, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee, and the Additional 2029 Notes were issued pursuant to supplemental indentures, dated as of December 20, 2019, and June 11, 2020 (such indenture and supplemental indentures, collectively, the "2019 Indenture"). The 2019 Indenture contains substantially the same customary events of default and negative covenants as the 2021 Indenture.

Interest is payable on the 2029 Notes on April 15 and October 15 of each year. The Company paid interest of $18.6 million on the 2029 Notes during the three months ended December 31, 2022 and January 1, 2022, and paid interest of $37.2 million during the nine months ended December 31, 2022 and January 1, 2022.

Senior Notes due 2031

On September 29, 2020, the Company issued $700.0 million aggregate principal amount of its 3.375% senior notes due 2031 (the "2031 Notes"). The 2031 Notes will mature on April 1, 2031, unless earlier redeemed in accordance with their terms. The 2031 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

12

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

The 2031 Notes were issued pursuant to an indenture, dated as of September 29, 2020, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee (the "2020 Indenture"). The 2020 Indenture contains substantially the same customary events of default and negative covenants as the 2021 Indenture.

Interest is payable on the 2031 Notes on April 1 and October 1 of each year. The Company paid no interest on the 2031 Notes during the three months ended December 31, 2022 and January 1, 2022, and paid interest of $11.8 million during the nine months ended December 31, 2022 and January 1, 2022.

Fair Value of Long-Term Debt

The Company's debt is carried at amortized cost and is measured quarterly at fair value for disclosure purposes. The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of December 31, 2022 was $459.8 million, $777.8 million and $572.3 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of April 2, 2022 was $476.9 million, $852.6 million and $638.6 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The Company considers its debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2024 Notes, the 2029 Notes and the 2031 Notes currently trade over-the-counter, and the fair values were estimated based upon the value of the last trade at the end of the period.

Interest Expense

During the three and nine months ended December 31, 2022, the Company recognized total interest expense of $18.1 million and $54.2 million, respectively, primarily related to the 2024 Notes, the 2029 Notes and the 2031 Notes, partially offset by interest capitalized to property and equipment of $1.0 million and $3.0 million, respectively. During the three and nine months ended January 1, 2022, the Company recognized total interest expense of $16.3 million and $48.7 million, respectively, primarily related to the 2029 Notes and the 2031 Notes, partially offset by interest capitalized to property and equipment of $0.9 million and $2.8 million, respectively.

7. STOCK REPURCHASES

On November 2, 2022, the Company announced that its Board of Directors authorized a new share repurchase program to repurchase up to $2.0 billion of the Company's outstanding common stock, which included the remaining authorized dollar amount under a prior program terminated concurrent with the new authorization. Under the current program, share repurchases are made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which the Company repurchases its shares, the number of shares and the timing of any repurchases depends on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require the Company to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended, or terminated at any time without prior notice.

During the three and nine months ended December 31, 2022, the Company repurchased approximately 2.2 million and 7.2 million shares of its common stock for approximately $201.6 million and $711.7 million, respectively (including transaction costs) under the prior and current share repurchase programs. As of December 31, 2022, approximately $1,855.0 million remains available for repurchases under the current share repurchase program.

During the three and nine months ended January 1, 2022, the Company repurchased approximately 1.9 million and 4.8 million shares, respectively, of its common stock for approximately $302.0 million and $825.4 million, respectively (including transaction costs).

8. COMMITMENTS AND CONTINGENT LIABILITIES

Purchase Obligations

Amidst ongoing industry-wide supply constraints, the Company entered into a long-term capacity reservation agreement with a foundry supplier during the second quarter of fiscal 2022. Under this agreement, the Company was required to purchase, and

13

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

the foundry supplier was required to supply, a certain number of wafers (at predetermined sales prices) for calendar years 2022 through 2025. In connection with this agreement, the Company paid a refundable deposit (which was recorded in "Other non-current assets" in the Condensed Consolidated Balance Sheets), and if the purchase commitments per the agreement were not met, under certain circumstances the supplier could deduct the amount of the purchase shortfall from the prepaid refundable deposit at the end of each calendar year.

During fiscal 2023, the Company has experienced unexpectedly weakened demand for 5G handsets in China and EMEA primarily due to unprecedented disruption resulting from measures taken in China to control the COVID-19 pandemic and the conflict in Ukraine. As a result, the Company did not meet the minimum purchase commitments under this long-term capacity reservation agreement.

In the first quarter of fiscal 2023, the purchase shortfall resulted in an impairment to the prepaid refundable deposit of approximately $13.0 million and additional reserves of approximately $11.0 million for inventory in excess of demand forecasts were recorded. Additionally, the Company assessed the future minimum purchase commitments over the remaining term of the agreement and recorded an estimated shortfall of $86.0 million, of which $8.0 million was recorded in "Other current liabilities" and $78.0 million was recorded in "Other long-term liabilities" in accordance with Accounting Standards Codification ("ASC") 330, "Inventory." These transactions resulted in a total increase to cost of goods sold of $110.0 million in the first quarter of fiscal 2023.

In October 2022, the Company renegotiated the terms of the agreement with the foundry supplier, which included extending the duration of the agreement through calendar year 2026. The Company believes that the amended agreement more closely aligns the contractual purchase commitments with forecasted demand. As a result of the amended agreement, in the second quarter of fiscal 2023, the Company recorded an impairment to the prepaid refundable deposit of approximately $38.0 million and additional reserves of approximately $5.0 million for inventory in excess of demand forecasts, which reduced the estimated shortfall liability that was previously recorded by $43.0 million. In the third quarter of fiscal 2023, the Company recorded an impairment to the prepaid refundable deposit of approximately $8.0 million and additional reserves of approximately $4.0 million for inventory in excess of demand forecasts, which reduced the estimated shortfall liability that was previously recorded by $12.0 million. There was no impact to the statements of operations in the second or third quarters of fiscal 2023. There were no material changes to the Company's estimated future purchase obligations under the current terms of the capacity reservation agreement during the current quarter.

In performing these assessments, the Company considered Company-specific forecasts, legal obligations, macroeconomic and geopolitical factors as well as market and industry trends. These factors include significant management judgment and estimates and, to the extent that these assumptions are incorrect or there are further declines in management's demand forecasts, additional charges may be recorded in future periods.

Legal Matters

The Company is involved in various legal proceedings and claims that have arisen in the ordinary course of business that have not been fully adjudicated. The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company regularly evaluates developments in its legal matters that could affect the amount of the previously accrued liability and records adjustments as appropriate. Although it is not possible to predict with certainty the outcome of the unresolved legal matters, it is the opinion of management that these matters will not, individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position or results of operations. The aggregate range of reasonably possible losses in excess of accrued liabilities, if any, associated with these unresolved legal matters is not material.

14

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

9. REVENUE

The following table presents the Company's revenue disaggregated by geography, based on the location of the customers' headquarters (in thousands):

	Three Months Ended				Nine Months Ended
	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
United States	$	459,194	$	569,494	$	1,470,231	$	1,449,667
China	124,799		273,582		630,012		1,227,782
Other Asia	72,002		136,089		390,690		364,855
Taiwan	53,072		76,432		274,707		253,713
Europe	34,214		58,360		171,056		183,539
Total revenue	$	743,281	$	1,113,957	$	2,936,696	$	3,479,556

The Company also disaggregates revenue by operating segments (refer to Note 11).

10. RESTRUCTURING

In fiscal 2023, the Company has taken actions to improve efficiencies in its operations and further align the organization with its strategic objectives.  The Company will continue to evaluate its operating footprint, cost structure and strategic opportunities.

The following table summarizes the charges resulting from the restructuring actions (in thousands):

	Three Months Ended December 31, 2022						Nine Months Ended December 31, 2022
	Cost of Goods Sold		Other Operating Expense		Total		Cost of Goods Sold		Other Operating Expense		Total
Contract termination and other costs	$	3,600	$	11,509	$	15,109	$	3,600	$	13,433	$	17,033
Asset impairment costs (1)	—		12,899		12,899		—		12,899		12,899
One-time employee termination benefits (2)	—		(623)		(623)		—		2,547		2,547
Total	$	3,600	$	23,785	$	27,385	$	3,600	$	28,879	$	32,479

(1) Relates to the adjustment of certain property and equipment to reflect its fair value.

(2) Includes reversal due to adjustment of previously accrued restructuring charges.

The following table summarizes the activity related to the Company's restructuring liabilities for the nine months ended December 31, 2022 (in thousands):

	One-Time Employee Termination Benefits		Contract Termination and Other Costs		Total
Accrued restructuring balance as of April 2, 2022	$	—	$	—	$	—
Costs incurred and charged to expense	2,547		17,033		19,580
Cash payments	(2,022)		(967)		(2,989)
Accrued restructuring balance as of December 31, 2022	$	525	$	16,066	$	16,591

15

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

11. OPERATING SEGMENT INFORMATION

In the second quarter of fiscal 2023, the Company updated its organizational structure from two operating segments (Mobile Products and Infrastructure and Defense Products) to three operating segments (High Performance Analog ("HPA"), Connectivity and Sensors Group ("CSG") and Advanced Cellular Group ("ACG")). This change was made to more closely align similar technologies and applications with customers and end markets, which represents how the Company currently manages its three operating segments (which are also its reportable segments). The Company's Chief Executive Officer, who is also the Company's chief operating decision maker ("CODM"), allocates resources and evaluates the performance of each of the three operating segments primarily based on operating income. All prior-period segment data has been retrospectively adjusted to reflect these three operating segments.

HPA is a leading global supplier of RF and power management solutions for infrastructure, defense and aerospace, automotive power and other markets. HPA leverages a diverse portfolio of differentiated technologies and products to support multiyear growth trends, including electrification, renewable energy, the increasing semiconductor spend in defense and 5G deployments outside of China.

CSG is a leading global supplier of connectivity and sensor components and systems featuring multiple technologies such as UWB, Matter®, Bluetooth® Low Energy, Zigbee®, Thread®, Wi-Fi®, cellular IoT and MEMS-/BAW-based sensors. CSG combines the connectivity and sensors businesses formerly split between Mobile Products and Infrastructure and Defense Products. CSG’s markets include smart home, automotive connectivity, industrial automation, smartphones, wearables, gaming and other high-growth IoT connectivity and healthcare markets.

ACG is a leading global supplier of cellular RF solutions for smartphones, wearables, laptops, tablets and various other devices. ACG leverages world-class technology and systems-level expertise to deliver a broad portfolio of high performance cellular products to the world's leading smartphone and consumer electronics companies. ACG is a highly diversified supplier of custom and open market cellular solutions, serving iOS and Android original equipment manufacturers.

The "All other" category includes operating expenses such as stock-based compensation expense, amortization of intangible assets, restructuring related charges, acquisition and integration related costs, charges associated with a long-term capacity reservation agreement, fixed asset impairments, gain (loss) on sale of fixed assets, start-up costs and other miscellaneous corporate overhead expenses that the Company does not allocate to its reportable segments because these expenses are not included in the segment operating performance measures evaluated by the Company’s CODM. The CODM does not evaluate operating segments using discrete asset information. The Company’s operating segments do not record intercompany revenue. The Company does not allocate gains and losses from investments, interest expense, other (expense) income, or taxes to operating segments. Except as discussed above regarding the "All other" category, the Company’s accounting policies for segment reporting are the same as for the Company as a whole.

16

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands):

	Three Months Ended				Nine Months Ended
	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Revenue:
HPA	$	155,011	$	181,876	$	594,094	$	496,842
CSG	96,810		157,578		392,454		525,190
ACG	491,460		774,503		1,950,148		2,457,524
Total revenue	$	743,281	$	1,113,957	$	2,936,696	$	3,479,556
Operating income (loss):
HPA	$	29,836	$	56,951	$	181,102	$	140,953
CSG	(31,145)		21,109		(29,926)		77,287
ACG	99,862		293,948		569,439		956,215
All other	(89,824)		(75,998)		(348,465)		(218,983)
Operating income	8,729		296,010		372,150		955,472
Interest expense	(17,066)		(15,328)		(51,222)		(45,934)
Other income, net	5,562		2,532		2,714		24,077
(Loss) income before income taxes	$	(2,775)	$	283,214	$	323,642	$	933,615

	Three Months Ended				Nine Months Ended
	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Reconciliation of "All other" category:
Stock-based compensation expense	$	(19,708)	$	(19,307)	$	(86,911)	$	(73,236)
Amortization of intangible assets	(32,844)		(38,443)		(99,283)		(112,243)
Restructuring related charges (1)	(27,385)		—		(32,479)		—
Acquisition and integration related costs	(6,296)		(6,552)		(21,246)		(16,585)
Charges associated with a long-term capacity reservation agreement (2)	—		—		(110,000)		—
Other	(3,591)		(11,696)		1,454		(16,919)
Loss from operations for "All other"	$	(89,824)	$	(75,998)	$	(348,465)	$	(218,983)

(1) Refer to Note 10 for additional information.

(2) Refer to Note 8 for additional information.

12. INCOME TAXES

The Company’s income tax expense was $13.2 million and $82.1 million for the three and nine months ended December 31, 2022, respectively, and $67.0 million and $112.5 million, for the three and nine months ended January 1, 2022, respectively. The Company’s effective tax rate was (474.1)% and 25.4% for the three and nine months ended December 31, 2022, respectively, and 23.6% and 12.1% for the three and nine months ended January 1, 2022, respectively.

The Company's effective tax rate for the three and nine months ended December 31, 2022 differed from the statutory rate primarily due to tax rate differences in foreign jurisdictions, global intangible low tax income ("GILTI"), domestic tax credits generated and discrete tax items recorded during the period. A discrete tax expense of $2.2 million and a discrete tax benefit of $10.4 million was recorded for the three and nine months ended December 31, 2022. The discrete tax expense for the three months ended December 31, 2022 primarily resulted from foreign currency gains recognized for tax purposes. The discrete tax benefit for the nine months ended December 31, 2022 primarily resulted from certain charges associated with a long-term

17

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

capacity reservation agreement (refer to Note 8 for further information), partially offset by foreign currency gains recognized for tax purposes.

The Company's effective tax rate for the three and nine months ended January 1, 2022 differed from the statutory rate primarily due to tax rate differences in foreign jurisdictions, GILTI, domestic tax credits and discrete tax items recorded during the period. A discrete tax expense of $42.5 million and $12.0 million was recorded during the three and nine months ended January 1, 2022, respectively. The discrete tax expense for the three and nine months ended January 1, 2022 primarily related to the revaluation of deferred tax assets due to the extension of the Company’s tax holiday in Singapore. The discrete tax expense for the nine months ended January 1, 2022 was partially offset by the recognition of previously unrecognized tax benefits due to the expiration of the statute of limitations, stock-based compensation deductions and net tax benefits associated with other non-recurring restructuring activities, including a discrete charge associated with the intercompany restructuring of the NextInput intellectual property.

13. NET (LOSS) INCOME PER SHARE

The following table sets forth the computation of basic and diluted net (loss) income per share (in thousands, except per share data):

	Three Months Ended				Nine Months Ended
	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Numerator:
Numerator for basic and diluted net (loss) income per share — net (loss) income available to common stockholders	$	(15,931)	$	216,263	$	241,568	$	821,078
Denominator:
Denominator for basic net (loss) income per share — weighted average shares	100,943		109,687		103,039		110,966
Effect of dilutive securities:
Stock-based awards	—		1,123		773		1,449
Denominator for diluted net (loss) income per share — adjusted weighted average shares and assumed conversions	100,943		110,810		103,812		112,415
Basic net (loss) income per share	$	(0.16)	$	1.97	$	2.34	$	7.40
Diluted net (loss) income per share	$	(0.16)	$	1.95	$	2.33	$	7.30

In the computation of net loss per share for the three months ended December 31, 2022, approximately 2.0 million shares of outstanding stock-based awards were excluded because the effect of their inclusion would have been anti-dilutive. In the computation of diluted net income per share for the nine months ended December 31, 2022, approximately 0.9 million shares of outstanding stock-based awards were excluded because the effect of their inclusion would have been anti-dilutive. An immaterial number of shares of outstanding stock-based awards were excluded from the computation of diluted net income per share for the three and nine months ended January 1, 2022 because the effect of their inclusion would have been anti-dilutive.

18

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q includes "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations and contentions, and are not historical facts and typically are identified by use of terms such as "may," "will," "should," "could," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue" and similar words, although some forward-looking statements are expressed differently. You should be aware that the forward-looking statements included herein represent management's current judgment and expectations, but our actual results, events and performance could differ materially from those expressed or implied by forward-looking statements. We do not intend to update any of these forward-looking statements or publicly announce the results of any revisions to these forward-looking statements, other than as is required under U.S. federal securities laws. Our business is subject to numerous risks and uncertainties, including those relating to fluctuations in our operating results; our substantial dependence on developing new products and achieving design wins; our dependence on several large customers for a substantial portion of our revenue; continued volatility and uncertainty in customer demand, worldwide economies and financial markets resulting from the impact of the COVID-19 pandemic, conflict in Ukraine or other macroeconomic factors; a loss of revenue if defense and aerospace contracts are canceled or delayed; our dependence on third parties; risks related to sales through distributors; risks associated with the operation of our manufacturing facilities; business disruptions; poor manufacturing yields; increased inventory risks and costs, including under long-term supply agreements, due to timing of customers' forecasts; our inability to effectively manage or maintain evolving relationships with chipset suppliers; our ability to continue to innovate in a very competitive industry; underutilization of manufacturing facilities; unfavorable changes in interest rates, pricing of certain precious metals, utility rates and foreign currency exchange rates; our acquisitions and other strategic investments failing to achieve financial or strategic objectives; our ability to attract, retain and motivate key employees; warranty claims, product recalls and product liability; changes in our effective tax rate; changes in the favorable tax status of certain of our subsidiaries; enactment of international or domestic tax legislation, or changes in regulatory guidance; risks associated with environmental, health and safety regulations, and climate change; risks from international sales and operations; economic regulation in China; changes in government trade policies, including imposition of tariffs and export restrictions; we may not be able to generate sufficient cash to service all of our debt; restrictions imposed by the agreements governing our debt; our reliance on our intellectual property portfolio; claims of infringement of third-party intellectual property rights; security breaches and other similar disruptions compromising our information; theft, loss or misuse of personal data by or about our employees, customers or third parties; provisions in our governing documents and Delaware law may discourage takeovers and business combinations that our stockholders might consider to be in their best interests; and volatility in the price of our common stock. These and other risks and uncertainties, which are described in more detail under "Risk Factors" in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended April 2, 2022 and Qorvo's subsequent reports and statements that we file with the SEC, could cause actual results and developments to be materially different from those expressed or implied by any of these forward-looking statements.

19

OVERVIEW

The following Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is intended to help the reader understand the consolidated results of operations and financial condition of Qorvo. MD&A is provided as a supplement to, and should be read in conjunction with, our Condensed Consolidated Financial Statements and accompanying Notes to Condensed Consolidated Financial Statements.

Qorvo is a global leader in the development and commercialization of technologies and products for wireless, wired and power markets.

During the second quarter of fiscal 2023, we updated our organizational structure to more closely align similar technologies and applications with customers and end markets. We manage our business and report our financial results in three reportable segments: High Performance Analog ("HPA"), Connectivity and Sensors Group ("CSG") and Advanced Cellular Group ("ACG"). Refer to Note 11 of the Notes to Condensed Consolidated Financial Statements for additional information regarding our reportable operating segments as of December 31, 2022.

HPA is a leading global supplier of RF and power management solutions for infrastructure, defense and aerospace, automotive power and other markets. HPA leverages a diverse portfolio of differentiated technologies and products to support multiyear growth trends, including electrification, renewable energy, the increasing semiconductor spend in defense and 5G deployments outside of China.

CSG is a leading global supplier of connectivity and sensor components and systems featuring multiple technologies such as UWB, Matter®, Bluetooth® Low Energy, Zigbee®, Thread®, Wi-Fi®, cellular IoT and MEMS-/BAW-based sensors. CSG combines the connectivity and sensors businesses formerly split between Mobile Products and Infrastructure and Defense Products. CSG’s markets include smart home, automotive connectivity, industrial automation, smartphones, wearables, gaming and other high-growth IoT connectivity and healthcare markets.

ACG is a leading global supplier of cellular RF solutions for smartphones, wearables, laptops, tablets and various other devices. ACG leverages world-class technology and systems-level expertise to deliver a broad portfolio of high performance cellular products to the world's leading smartphone and consumer electronics companies. ACG is a highly diversified supplier of custom and open market cellular solutions serving iOS and Android original equipment manufacturers.

As previously disclosed in our Annual Report on Form 10-K, filed on May 20, 2022, the COVID-19 pandemic has impacted the semiconductor industry supply chain, causing uncertainty in customer demand, worldwide economies and financial markets. During fiscal 2023, we have experienced unexpectedly weakened demand for 5G handsets in China and EMEA due to unprecedented disruption resulting from measures taken in China to control the COVID-19 pandemic and the conflict in Ukraine. As a result, we did not meet the minimum purchase commitments under a long-term capacity reservation agreement with a foundry supplier. In the first quarter of fiscal 2023, the purchase shortfall resulted in an impairment to the prepaid refundable deposit of approximately $13.0 million and additional reserves of approximately $11.0 million for inventory in excess of demand forecasts were recorded. Additionally, we assessed the future minimum purchase commitments over the remaining term of the agreement and recorded an estimated shortfall of $86.0 million in accordance with Accounting Standards Codification 330, "Inventory." These transactions resulted in a total increase to cost of goods sold of $110.0 million in the first quarter of fiscal 2023. In October 2022, we renegotiated the terms of the agreement with the foundry supplier, which included extending the duration of the agreement through calendar year 2026. We believe that the amended agreement more closely aligns the contractual purchase commitments with our forecasted demand. As a result of the amended agreement, in the second quarter of fiscal 2023, we recorded an impairment to the prepaid refundable deposit of approximately $38.0 million and additional reserves of approximately $5.0 million for inventory in excess of demand forecasts, which reduced the estimated shortfall liability that was previously recorded by $43.0 million. In the third quarter of fiscal 2023, we recorded an impairment to the prepaid refundable deposit of approximately $8.0 million and additional reserves of approximately $4.0 million for inventory in excess of demand forecasts, which reduced the estimated shortfall liability that was previously recorded by $12.0 million. There was no impact to the statements of operations in the second or third quarters of fiscal 2023. In performing these assessments, we considered Company-specific forecasts, legal obligations, macroeconomic and geopolitical factors as well as market and industry trends. These factors include significant management judgment and estimates and, to the extent that these assumptions are incorrect or there are further declines in management's demand forecasts, additional charges may be recorded in future periods.

20

THIRD QUARTER FISCAL 2023 FINANCIAL HIGHLIGHTS

•Revenue for the third quarter of fiscal 2023 decreased 33.3% as compared to the third quarter of fiscal 2022, primarily due to ongoing global macroeconomic challenges which resulted in lower demand for 5G handsets and other consumer facing products, such as Wi-Fi. Demand was also negatively impacted by ongoing efforts to consume channel inventories.

•Gross margin for the third quarter of fiscal 2023 decreased to 36.1% as compared to 49.2% for the third quarter of fiscal 2022, primarily due to factory underutilization costs resulting from lower production levels, as well as inventory charges related to demand fluctuations and a quality issue from a third-party supplier. These decreases to gross margin were partially offset by favorable changes in product mix.

•Operating income was $8.7 million for the third quarter of fiscal 2023 as compared to $296.0 million for the third quarter of fiscal 2022. This decrease was primarily due to lower revenue and lower gross margin.

•Net loss per share was $0.16 for the third quarter of fiscal 2023 as compared to net income per diluted share of $1.95 for the third quarter of fiscal 2022.

•Capital expenditures were $34.4 million for the third quarter of fiscal 2023 as compared to $50.5 million for the third quarter of fiscal 2022.

•During the third quarter of fiscal 2023, we repurchased approximately 2.2 million shares of our common stock for approximately $201.6 million.

21

RESULTS OF OPERATIONS

Consolidated

The following tables present a summary of our results of operations (in thousands, except percentages): 

	Three Months Ended
	December 31, 2022		% of Revenue		January 1, 2022		% of Revenue		Increase (Decrease)		Percentage Change
Revenue	$	743,281	100.0	%	$	1,113,957	100.0	%	$	(370,676)	(33.3)	%
Cost of goods sold	475,230		63.9		565,864		50.8		(90,634)		(16.0)
Gross profit	268,051		36.1		548,093		49.2		(280,042)		(51.1)
Research and development	149,472		20.1		154,435		13.9		(4,963)		(3.2)
Selling, general and administrative	76,269		10.3		82,003		7.3		(5,734)		(7.0)
Other operating expense	33,581		4.5		15,645		1.4		17,936		114.6
Operating income	$	8,729	1.2	%	$	296,010	26.6	%	$	(287,281)	(97.1)	%
	Nine Months Ended
	December 31, 2022		% of Revenue		January 1, 2022		% of Revenue		Increase (Decrease)		Percentage Change
Revenue	$	2,936,696	100.0	%	$	3,479,556	100.0	%	$	(542,860)	(15.6)	%
Cost of goods sold	1,754,468		59.7		1,763,727		50.7		(9,259)		(0.5)
Gross profit	1,182,228		40.3		1,715,829		49.3		(533,601)		(31.1)
Research and development	486,204		16.6		464,891		13.4		21,313		4.6
Selling, general and administrative	275,836		9.4		265,791		7.6		10,045		3.8
Other operating expense	48,038		1.6		29,675		0.8		18,363		61.9
Operating income	$	372,150	12.7	%	$	955,472	27.5	%	$	(583,322)	(61.1)	%

Revenue decreased for the three and nine months ended December 31, 2022, compared to the three and nine months ended January 1, 2022, primarily due to ongoing global macroeconomic challenges (including the measures taken in China to control the COVID-19 pandemic, the conflict in Ukraine and the negative impact of higher inflation on consumer spending) which resulted in lower demand for 5G handsets and other consumer facing products, such as Wi-Fi. Demand was also negatively impacted by ongoing efforts to consume channel inventories. The decreased revenue for the nine months ended December 31, 2022, compared to the nine months ended January 1, 2022, was partially offset by content gains in mass-tier handsets and higher demand for our defense and silicon carbide ("SiC")-based power management products.

Gross margin decreased for the three months ended December 31, 2022, compared to the three months ended January 1, 2022, primarily due to factory underutilization costs resulting from lower production levels, as well as inventory charges related to demand fluctuations and a quality issue from a third-party supplier. These decreases to gross margin were partially offset by favorable changes in product mix.

Gross margin decreased for the nine months ended December 31, 2022, compared to the nine months ended January 1, 2022, primarily due to charges recorded in the first quarter of fiscal 2023 associated with a long-term capacity reservation agreement, factory underutilization costs resulting from lower production levels, as well as inventory charges related to demand fluctuations and quality issues from third-party suppliers. These decreases to gross margin were partially offset by favorable changes in product mix.

Operating expenses increased for the three months ended December 31, 2022, compared to the three months ended January 1, 2022, primarily due to restructuring charges (see Note 10 of the Notes to Condensed Consolidated Financial Statements for additional information), partially offset by lower employee-related costs.

22

Operating expenses increased for the nine months ended December 31, 2022, compared to the nine months ended January 1, 2022, primarily due to employee-related costs and restructuring charges. Travel expenses also increased during the nine months ended December 31, 2022, as travel restrictions and our policies originally implemented in response to the COVID-19 pandemic have eased.

Operating Segments

High Performance Analog

	Three Months Ended
(In thousands, except percentages)	December 31, 2022			January 1, 2022			Decrease		Percentage Change
Revenue	$	155,011		$	181,876		$	(26,865)	(14.8)	%
Operating income	29,836			56,951			(27,115)		(47.6)
Operating income as a % of revenue	19.2		%	31.3		%
	Nine Months Ended
(In thousands, except percentages)	December 31, 2022			January 1, 2022			Increase		Percentage Change
Revenue	$	594,094		$	496,842		$	97,252	19.6	%
Operating income	181,102			140,953			40,149		28.5
Operating income as a % of revenue	30.5		%	28.4		%

HPA revenue decreased for the three months ended December 31, 2022, compared to the three months ended January 1, 2022, primarily due to a decrease in demand for base station products and power products supporting solid-state drives and power tools, driven by ongoing efforts to consume channel inventories. These decreases were partially offset by higher demand for our SiC-based power management products.

HPA revenue increased for the nine months ended December 31, 2022, compared to the nine months ended January 1, 2022, primarily due to higher demand for our defense, SiC-based power management and base station products. These increases were partially offset by a decrease in demand for power products supporting solid-state drives and power tools, driven by ongoing efforts to consume channel inventories.

HPA operating income decreased for the three months ended December 31, 2022, compared to the three months ended January 1, 2022, primarily due to the effects of decreased revenue, including factory underutilization.

HPA operating income increased for the nine months ended December 31, 2022, compared to the nine months ended January 1, 2022, primarily due to increased revenue and lower inventory charges, partially offset by factory underutilization.

Connectivity and Sensors Group

	Three Months Ended
(In thousands, except percentages)	December 31, 2022			January 1, 2022			Decrease		Percentage Change
Revenue	$	96,810		$	157,578		$	(60,768)	(38.6)	%
Operating (loss) income	(31,145)			21,109			(52,254)		(247.5)
Operating (loss) income as a % of revenue	(32.2)		%	13.4		%
	Nine Months Ended
(In thousands, except percentages)	December 31, 2022			January 1, 2022			Decrease		Percentage Change
Revenue	$	392,454		$	525,190		$	(132,736)	(25.3)	%
Operating (loss) income	(29,926)			77,287			(107,213)		(138.7)
Operating (loss) income as a % of revenue	(7.6)		%	14.7		%

23

CSG revenue decreased for the three and nine months ended December 31, 2022, compared to the three and nine months ended January 1, 2022, primarily due to a decrease in end market demand for Wi-Fi components in addition to ongoing efforts to consume channel inventories.

CSG operating income decreased for the three and nine months ended December 31, 2022, compared to the three and nine months ended January 1, 2022, primarily due to decreased revenue, factory underutilization and higher inventory charges.

Advanced Cellular Group

	Three Months Ended
(In thousands, except percentages)	December 31, 2022			January 1, 2022			Decrease		Percentage Change
Revenue	$	491,460		$	774,503		$	(283,043)	(36.5)	%
Operating income	99,862			293,948			(194,086)		(66.0)
Operating income as a % of revenue	20.3		%	38.0		%
	Nine Months Ended
(In thousands, except percentages)	December 31, 2022			January 1, 2022			Decrease		Percentage Change
Revenue	$	1,950,148		$	2,457,524		$	(507,376)	(20.6)	%
Operating income	569,439			956,215			(386,776)		(40.4)
Operating income as a % of revenue	29.2		%	38.9		%

ACG revenue decreased for the three and nine months ended December 31, 2022, compared to the three and nine months ended January 1, 2022, primarily due to ongoing global macroeconomic challenges (including the measures taken in China to control the COVID-19 pandemic, the conflict in Ukraine and the negative impact of higher inflation on consumer spending) which resulted in lower demand for 5G handsets. Demand for ACG products was also negatively impacted by ongoing efforts to consume channel inventories. The decreased revenue for the nine months ended December 31, 2022, compared to the nine months ended January 1, 2022, was partially offset by content gains in mass-tier handsets.

ACG operating income decreased for the three and nine months ended December 31, 2022, compared to the three and nine months ended January 1, 2022, primarily due to factory underutilization costs resulting from lower production levels, as well as inventory charges related to demand fluctuations and quality issues from third-party suppliers. These decreases to operating income were partially offset by favorable changes in customer mix. Operating expenses increased for the nine months ended December 31, 2022, compared to the nine months ended January 1, 2022, primarily due to employee-related costs.

Refer to Note 11 of the Notes to Condensed Consolidated Financial Statements for a reconciliation of reportable segment operating income to the consolidated operating income for the three and nine months ended December 31, 2022 and January 1, 2022.

INTEREST, OTHER INCOME (EXPENSE) AND INCOME TAXES

	Three Months Ended				Nine Months Ended
(In thousands)	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Interest expense	$	(17,066)	$	(15,328)	$	(51,222)	$	(45,934)
Other income, net	5,562		2,532		2,714		24,077
Income tax expense	(13,156)		(66,951)		(82,074)		(112,537)

Interest expense

During the three and nine months ended December 31, 2022, we recorded interest expense primarily related to our 1.750% senior notes due 2024 (the "2024 Notes"), our 4.375% senior notes due 2029 (the "2029 Notes") and our 3.375% senior notes due 2031 (the "2031 Notes"). During the three and nine months ended January 1, 2022, we recorded interest expense primarily related to our 2029 Notes and our 2031 Notes. Refer to Note 6 of the Notes to Condensed Consolidated Financial Statements for additional information.

Other income, net

Other income is primarily attributed to interest income as well as gains (losses) from our share of investments in limited partnerships and gains (losses) from other investments. Refer to Note 5 of the Notes to Condensed Consolidated Financial Statements for additional information.

Income tax expense

During the three and nine months ended December 31, 2022, we recorded income tax expense of $13.2 million and $82.1 million, respectively, comprised primarily of tax expense related to international operations generating pre-tax book income and the impact of global intangible low tax income, partially offset by tax benefits related to domestic and international operations generating pre-tax book losses and domestic tax credits and discrete tax items recorded during the period. The discrete tax expense for the three months ended December 31, 2022 primarily resulted from foreign currency gains recognized for tax purposes. The discrete tax benefit for the nine months ended December 31, 2022 primarily resulted from certain charges associated with a long-term capacity reservation agreement (refer to Note 8 of the Notes to Condensed Consolidated Financial Statements for further information), partially offset by foreign currency gains recognized for tax purposes.

During the three and nine months ended January 1, 2022, we recorded income tax expense of $67.0 million and $112.5 million, respectively, comprised primarily of tax expense related to domestic and international operations generating pre-tax book income and discrete charges recorded during the period, partially offset by tax benefits related to international operations generating pre-tax book losses and domestic tax credits. The discrete tax expense for the three and nine months ended January 1, 2022 primarily related to the revaluation of deferred tax assets due to the extension of the Company’s tax holiday in Singapore through December 31, 2031. The discrete tax expense for the nine months ended January 1, 2022 was partially offset by the recognition of previously unrecognized tax benefits due to the expiration of the statute of limitations, stock-based compensation deductions and net tax benefits associated with other non-recurring restructuring activities, including a discrete charge associated with the intercompany restructuring of the NextInput, Inc. ("NextInput") intellectual property.

A valuation allowance remained against certain domestic and foreign net deferred tax assets as it is more likely than not that the related deferred tax assets will not be realized.

LIQUIDITY AND CAPITAL RESOURCES

Cash generated by operations is our primary source of liquidity. As of December 31, 2022, we had working capital of approximately $1,644.1 million, including $918.8 million in cash and cash equivalents, compared to working capital of approximately $1,774.7 million, including $972.6 million in cash and cash equivalents as of April 2, 2022.

Our $918.8 million of total cash and cash equivalents as of December 31, 2022, includes approximately $755.1 million held by our foreign subsidiaries, of which $585.0 million is held by Qorvo International Pte. Ltd. in Singapore. If the undistributed earnings of our foreign subsidiaries are needed in the U.S., we may be required to pay state income and/or foreign local withholding taxes to repatriate these earnings.

Stock Repurchases

During the nine months ended December 31, 2022, we repurchased approximately 7.2 million shares of our common stock for approximately $711.7 million (including transaction costs) under the prior and current share repurchase programs. As of December 31, 2022, approximately $1,855.0 million remains available for repurchases under the current program.

25

Cash Flows from Operating Activities

Net cash provided by operating activities was $777.8 million and $703.4 million for the nine months ended December 31, 2022 and January 1, 2022, respectively. This increase in cash provided by operating activities was primarily due to changes in working capital, partially offset by decreased profitability. In the nine months ended January 1, 2022, cash provided by operating activities was impacted by the increase in prepaid expenses and other assets primarily due to prepayments of certain fees and deposits associated with a long-term capacity reservation agreement.

Cash Flows from Investing Activities

Net cash used in investing activities was $117.4 million and $552.2 million for the nine months ended December 31, 2022 and January 1, 2022, respectively. There were no acquisitions during the nine months ended December 31, 2022, and we acquired NextInput and United Silicon Carbide, Inc. during the nine months ended January 1, 2022. Refer to Note 3 of the Notes to Condensed Consolidated Financial Statements for additional information regarding our business acquisitions.

Cash Flows from Financing Activities

Net cash used in financing activities was $714.0 million and $558.5 million for the nine months ended December 31, 2022 and January 1, 2022, respectively, primarily due to our stock repurchases and debt obligation activity. Refer to Notes 6 and 7 of the Notes to Condensed Consolidated Financial Statements for additional information regarding our long-term debt and stock repurchases, respectively.

COMMITMENTS AND CONTINGENCIES

Credit Agreement On September 29, 2020, we and certain of our U.S. subsidiaries (the "Guarantors") entered into a five-year unsecured senior credit facility pursuant to a credit agreement (as amended, restated, modified or otherwise supplemented from time to time, the "Credit Agreement") with Bank of America, N.A., acting as administrative agent, and a syndicate of lenders. The Credit Agreement amended and restated our previous credit agreement dated as of December 5, 2017. The Credit Agreement includes a senior revolving line of credit (the "Revolving Facility") of up to $300.0 million and included a senior term loan of $200.0 million (collectively, the "Credit Facility") which was fully repaid in fiscal 2022. The Revolving Facility includes a $25.0 million sublimit for the issuance of standby letters of credit and a $10.0 million sublimit for swing line loans. The Credit Facility is available to finance working capital, capital expenditures and other general corporate purposes.

Pursuant to the Credit Agreement, we may request one or more additional tranches of term loans or increases to the Revolving Facility, up to an aggregate of $500.0 million and subject to, among other things, securing additional funding commitments from the existing or new lenders.

During the nine months ended December 31, 2022, there were no borrowings under the Revolving Facility.

The Credit Agreement contains various conditions, covenants and representations with which we must be in compliance in order to borrow funds and to avoid an event of default. As of December 31, 2022, we were in compliance with these covenants.

2024 Notes On December 14, 2021, we issued $500.0 million aggregate principal amount of our 2024 Notes. Interest on the 2024 Notes is payable on June 15 and December 15 of each year at a rate of 1.750% per annum. The 2024 Notes will mature on December 15, 2024, unless earlier redeemed in accordance with their terms. The 2024 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

2029 Notes On September 30, 2019, we issued $350.0 million aggregate principal amount of our senior notes due 2029 (the "Initial 2029 Notes"). On December 20, 2019, and June 11, 2020, we issued an additional $200.0 million and $300.0 million, respectively, aggregate principal amount of such notes (together with the Initial 2029 Notes, the "2029 Notes"). Interest on the 2029 Notes is payable on April 15 and October 15 of each year at a rate of 4.375% per annum. The 2029 Notes will mature on October 15, 2029, unless earlier redeemed in accordance with their terms. The 2029 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

2031 Notes On September 29, 2020, we issued $700.0 million aggregate principal amount of our 2031 Notes. Interest on the 2031 Notes is payable on April 1 and October 1 of each year at a rate of 3.375% per annum. The 2031 Notes will mature on April 1, 2031, unless earlier redeemed in accordance with their terms. The 2031 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

26

For additional information regarding our long-term debt, refer to Note 6 of the Notes to Condensed Consolidated Financial Statements.

Capital Commitments As of December 31, 2022, we had capital commitments of approximately $84.9 million primarily for expanding capability to support new products, equipment and facility upgrades and cost savings initiatives.

Purchase Obligations Refer to Note 8 of the Notes to Condensed Consolidated Financial Statements for additional information regarding our purchase obligations.

Future Sources of Funding Our future capital requirements may differ materially from those currently projected and will depend on many factors, including market acceptance of and demand for our products, acquisition opportunities, technological advances and our relationships with suppliers and customers. Based on current and projected levels of cash flows from operations, coupled with our existing cash, cash equivalents and our Credit Facility, we believe we have sufficient liquidity to meet both our short-term and long-term cash requirements. However, if there is a significant decrease in demand for our products, or if our demand grows faster than we anticipate, operating cash flows may be insufficient to meet our needs. If existing resources and cash from operations are not sufficient to meet our future requirements or if we perceive conditions to be favorable, we may seek additional debt or equity financing. Additional debt or equity financing could be dilutive to holders of our common stock. Further, we cannot be sure that any additional debt or equity financing, if required, will be available on favorable terms, if at all.

Legal We are involved in various legal proceedings and claims that have arisen in the ordinary course of business that have not been fully adjudicated. We accrue a liability for legal contingencies when we believe that it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. We regularly evaluate developments in our legal matters that could affect the amount of the previously accrued liability and record adjustments as appropriate. Although it is not possible to predict with certainty the outcome of the unresolved legal matters, it is the opinion of management that these matters will not, individually or in the aggregate, have a material adverse effect on our consolidated financial position or results of operations. We believe the aggregate range of reasonably possible losses in excess of accrued liabilities, if any, associated with these unresolved legal matters is not material.

Taxes We are subject to income and other taxes in the United States and in numerous foreign jurisdictions. Our domestic and foreign tax liabilities are subject to the allocation of revenues and expenses in different jurisdictions. Additionally, the amount of taxes paid is subject to our interpretation of applicable tax laws in the jurisdictions in which we operate. We are subject to audits by tax authorities. While we endeavor to comply with all applicable tax laws, there can be no assurance that a governing tax authority will not have a different interpretation of the law than we do or that we will comply in all respects with applicable tax laws, which could result in additional taxes. There can be no assurance that the outcomes from tax audits will not have an adverse effect on our results of operations in the period during which the review is conducted.

SUPPLEMENTAL PARENT AND GUARANTOR FINANCIAL INFORMATION

In accordance with the indentures governing the 2024 Notes, the 2029 Notes and the 2031 Notes (together, the "Notes"), our obligations under the Notes are fully and unconditionally guaranteed on a joint and several unsecured basis by the Guarantors, which are listed on Exhibit 22 to this Quarterly Report on Form 10-Q. Each Guarantor is 100% owned, directly or indirectly, by Qorvo, Inc. ("Parent"). A Guarantor can be released in certain customary circumstances. Our other U.S. subsidiaries and our non-U.S. subsidiaries do not guarantee the Notes (such subsidiaries are referred to as the "Non-Guarantors").

27

The following presents summarized financial information for the Parent and the Guarantors on a combined basis as of and for the periods indicated, after eliminating (i) intercompany transactions and balances among the Parent and Guarantors, and (ii) equity earnings from, and investments in, any Non-Guarantor. The summarized financial information may not necessarily be indicative of the financial position and results of operations had the combined Parent and Guarantors operated independently from the Non-Guarantors.

Summarized Balance Sheets (in thousands)	December 31, 2022		April 2, 2022
ASSETS
Current assets (1)	$	910,455	$	771,528
Non-current assets	$	2,495,346	$	2,624,454
LIABILITIES
Current liabilities	$	216,933	$	241,674
Long-term liabilities (2)	$	2,711,093	$	2,634,501

(1) Includes net amounts due from Non-Guarantor subsidiaries of $391.4 million and $286.8 million as of December 31, 2022 and April 2, 2022, respectively.

(2) Includes net amounts due to Non-Guarantor subsidiaries of $490.0 million and $433.5 million as of December 31, 2022 and April 2, 2022, respectively.

Summarized Statement of Operations	Nine Months Ended
(in thousands)	December 31, 2022
Revenue	$	705,253
Gross profit	$	11,800
Net loss	$	(211,944)

28

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

There have been no material changes to our market risk exposures during the third quarter of fiscal 2023. For a discussion of our exposure to market risk, refer to Item 7A, "Quantitative and Qualitative Disclosures About Market Risk," contained in Qorvo's Annual Report on Form 10-K for the fiscal year ended April 2, 2022.

ITEM 4. CONTROLS AND PROCEDURES.

As of the end of the period covered by this report, the Company’s management, with the participation of the Company’s Chief Executive Officer ("CEO") and the Chief Financial Officer ("CFO"), evaluated the effectiveness of the Company’s disclosure controls and procedures in accordance with Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our CEO and CFO concluded that the Company’s disclosure controls and procedures were effective, as of such date, to enable the Company to record, process, summarize and report in a timely manner the information that the Company is required to disclose in its Exchange Act reports, and to accumulate and communicate such information to management, including the Company’s CEO and the CFO, as appropriate, to allow timely decisions regarding required disclosure.

There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended December 31, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

29

PART II — OTHER INFORMATION

ITEM 1A. RISK FACTORS.

Other than the risk factor set forth below, there have been no material changes to the risk factors identified in Part I, Item 1A., "Risk Factors" in Qorvo's Annual Report on Form 10-K for the fiscal year ended April 2, 2022.

We are subject to inventory risks and costs because we purchase materials and build our products based on forecasts provided by customers before receiving purchase orders for the products.

In order to ensure availability of our products for some of our largest end customers, we purchase materials and start manufacturing certain products in advance of receiving purchase orders based on forecasts provided by these customers. However, these forecasts do not represent binding purchase commitments and we do not recognize sales for these products until they are shipped to or consumed by the customer. As a result, we incur significant inventory and manufacturing costs in advance of anticipated sales. Because demand for our products may not materialize, or may be lower than expected, purchasing materials and manufacturing based on forecasts subjects us to heightened risks of higher inventory carrying costs, increased obsolescence and higher operating costs. These inventory risks are exacerbated when our customers purchase indirectly through contract manufacturers or hold component inventory levels greater than their consumption rate because this reduces our visibility regarding the customers’ accumulated levels of inventory.

For example, amidst ongoing industry-wide supply constraints, we entered into a long-term capacity reservation agreement with a foundry supplier during the second quarter ended October 2, 2021. Under the agreement we were required to purchase, and the supplier was required to supply, a certain number of wafers for calendar years 2022 through 2025. In connection with this agreement, we paid a refundable deposit and if the purchase commitments per the agreement were not met, under certain circumstances the supplier could deduct the amount of the purchase shortfall from the prepaid refundable deposit at the end of each calendar year.

During fiscal 2023, we have experienced unexpectedly weakened demand for 5G handsets in China and EMEA due to unprecedented disruption resulting from measures taken in China to control the COVID-19 pandemic and the conflict in Ukraine. As a result, we did not meet the minimum purchase commitments under this agreement, which resulted in the recognition of purchase shortfalls and an increase to our cost of goods sold in the first quarter of fiscal 2023.

In October 2022, we renegotiated the terms of the agreement with the foundry supplier, which included extending the duration of the agreement through calendar year 2026. We believe that the amended agreement more closely aligns the contractual purchase commitments with our forecasted demand. To the extent that management’s assumptions pertaining to anticipated future demand are incorrect or there are further declines in management's demand forecasts, additional charges may be recorded in future periods, which would have a negative impact on our gross margin and other operating results.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

(c) Issuer Purchases of Equity Securities

Period	Total number of shares purchased (in thousands)	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs (in thousands)	Approximate dollar value of shares that may yet be purchased under the plans or programs (in millions)
October 2, 2022 to October 29, 2022	686	$	81.36	686	$	295.9
October 30, 2022 to November 26, 2022	780	92.90		780	1,928.3
November 27, 2022 to December 31, 2022	765	95.86		765	1,855.0
Total	2,231	$	90.37	2,231	$	1,855.0

30

On November 2, 2022, we announced that our Board of Directors (the "Board") authorized a new share repurchase program to repurchase up to $2.0 billion of our outstanding common stock, which included the remaining authorized dollar amount under the prior program terminated concurrent with the new authorization. Under the current program, share repurchases are made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which we repurchase our shares, the number of shares and the timing of any repurchases depends on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require us to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended, or terminated at any time without prior notice.

ITEM 5. OTHER INFORMATION.

On November 9, 2022, the Board amended the bylaws of the Company (the “Restated Bylaws”) to address matters regarding nominations of directors. The Restated Bylaws, without limitation, (a) require additional information and representations in the notice(s) a stockholder is required to provide to the Company for director nominations, (b) modify the time period for which notices to the Company must be provided to be timely for the Company’s annual meeting of stockholders to not earlier than the close of business on the 150th day and not later than the close of business on the 120th day prior to the first anniversary of the preceding year's annual meeting, and (c) address matters relating to Rule 14a-19 under the Exchange Act.

The foregoing description of the Restated Bylaws is a summary and is qualified in its entirety by reference to the text of the Restated Bylaws, which is included as Exhibit 3.1 and is incorporated herein by reference.

31

ITEM 6. EXHIBITS.

 

3.1	Second Amended and Restated Bylaws of Qorvo, Inc., adopted on November 9, 2022 (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the SEC on November 10, 2022)
22	List of Subsidiary Guarantors
31.1	Certification of Periodic Report by Robert A. Bruggeworth, as Chief Executive Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Periodic Report by Grant A. Brown, as Chief Financial Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of Periodic Report by Robert A. Bruggeworth, as Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Periodic Report by Grant A. Brown, as Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101	The following materials from our Quarterly Report on Form 10-Q for the quarter ended December 31, 2022, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Operations; (iii) the Condensed Consolidated Statements of Comprehensive Income; (iv) the Condensed Consolidated Statements of Stockholders' Equity; (v) the Condensed Consolidated Statements of Cash Flows; and (vi) the Notes to Condensed Consolidated Financial Statements
104	The cover page from our Quarterly Report on Form 10-Q for the quarter ended December 31, 2022, formatted in iXBRL

Our SEC file number for documents filed with the SEC pursuant to the Securities Exchange Act of 1934, as amended, is 001-36801.

32

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		Qorvo, Inc.
Date:	February 2, 2023	/s/ Grant A. Brown
		Grant A. Brown
		Senior Vice President and Chief Financial Officer

33

EX-22

Exhibit 22

List of Subsidiary Guarantors

The 1.750% Senior Notes due 2024, the 4.375% Senior Notes due 2029 and the 3.375% Senior Notes due 2031 are guaranteed, jointly and severally, on an unsecured basis, by the following 100% owned subsidiaries of Qorvo, Inc., a Delaware corporation, as of December 31, 2022:

Entity	Jurisdiction of Incorporation or Organization
Amalfi Semiconductor, Inc.	Delaware
RFMD, LLC	North Carolina
Qorvo California, Inc.	California
Qorvo US, Inc.	Delaware
Qorvo Texas, LLC	Texas
Qorvo Oregon, Inc.	Oregon

EX-31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF THE EXCHANGE ACT, AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Robert A. Bruggeworth, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Qorvo, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

     Date: February 2, 2023

/s/ ROBERT A. BRUGGEWORTH

Robert A. Bruggeworth

President and Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF THE EXCHANGE ACT, AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Grant A. Brown, certify that:

1.    I have reviewed this quarterly report on Form 10-Q of Qorvo, Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

    Date: February 2, 2023

/s/ GRANT A. BROWN

Grant A. Brown

Senior Vice President and Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Robert A. Bruggeworth, President and Chief Executive Officer of Qorvo, Inc. (the “Company”), certify pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to my knowledge:

(1)    the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended December 31, 2022 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ ROBERT A. BRUGGEWORTH

Robert A. Bruggeworth

President and Chief Executive Officer

February 2, 2023

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Grant A. Brown, Senior Vice President and Chief Financial Officer of Qorvo, Inc. (the “Company”), certify pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to my knowledge:

(1)    the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended December 31, 2022 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ GRANT A. BROWN

Grant A. Brown

Senior Vice President and Chief Financial Officer

February 2, 2023

XML

Cover Page - shares	9 Months Ended
	Dec. 31, 2022	Jan. 26, 2023
Cover [Abstract]
Document Transition Report	false
Document Quarterly Report	true
Title of 12(b) Security	Common Stock, $0.0001 par value
Entity Current Reporting Status	Yes
Entity Incorporation, State or Country Code	DE
Entity Registrant Name	Qorvo, Inc.
City Area Code	336
Entity Central Index Key	0001604778
Document Type	10-Q
Document Period End Date	Dec. 31, 2022
Entity File Number	001-36801
Amendment Flag	false
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--04-01
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Common Stock, Shares Outstanding		99,889,210
Entity Address, Address Line One	7628 Thorndike Road
Local Phone Number	664-1233
Entity Interactive Data Current	Yes
Entity Shell Company	false
Trading Symbol	QRVO
Security Exchange Name	NASDAQ
Entity Tax Identification Number	46-5288992
Entity Address, City or Town	Greensboro,
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	27409-9421
Document Fiscal Year Focus	2023

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Dec. 31, 2022	Apr. 02, 2022
Current assets:
Cash and cash equivalents	$ 918,758	$ 972,592
Accounts receivable, net of allowance of $405 and $402 as of December 31, 2022 and April 2, 2022, respectively	367,636	568,850
Inventories	857,277	755,748
Prepaid expenses	46,105	49,839
Other Receivables, Net, Current	30,832	32,151
Other current assets	37,092	70,685
Total current assets	2,257,700	2,449,865
Property and equipment, net of accumulated depreciation of $1,846,373 and $1,734,608 as of December 31, 2022 and April 2, 2022, respectively	1,191,986	1,253,591
Goodwill	2,770,146	2,775,634
Intangible assets, net	567,375	674,786
Long-term investments	24,218	31,086
Other non-current assets	264,794	324,110
Total assets	7,076,219	7,509,072
Current liabilities:
Accounts payable	225,111	327,915
Accrued liabilities	239,013	240,186
Other current liabilities	149,466	107,026
Total current liabilities	613,590	675,127
Long-Term Debt, Excluding Current Maturities	2,047,743	2,047,098
Other long-term liabilities	250,318	233,629
Total liabilities	2,911,651	2,955,854
Stockholders’ equity:
Preferred stock, $.0001 par value; 5,000 shares authorized; no shares issued and outstanding	0	0
Common stock and additional paid-in capital, $.0001 par value; 405,000 shares authorized; 100,021 and 106,303 shares issued and outstanding at December 31, 2022 and April 2, 2022, respectively	3,859,940	4,035,849
Accumulated other comprehensive (loss) income	(11,365)	5,232
Retained earnings	315,993	512,137
Total stockholders’ equity	4,164,568	4,553,218
Total liabilities and stockholders’ equity	$ 7,076,219	$ 7,509,072

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2022	Apr. 02, 2022
Statement of Financial Position [Abstract]
Allowance for accounts receivable	$ 405	$ 402
Property and equipment, accumulated depreciation	$ 1,846,373	$ 1,734,608
Preferred Stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common Stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	405,000,000	405,000,000
Common stock, shares issued	100,021,000	106,303,000
Common stock, shares outstanding	100,021,000	106,303,000

XML

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Dec. 31, 2022	Jan. 01, 2022
Income Statement [Abstract]
Revenues	$ 743,281	$ 1,113,957	$ 2,936,696	$ 3,479,556
Cost of goods sold	475,230	565,864	1,754,468	1,763,727
Gross profit	268,051	548,093	1,182,228	1,715,829
Operating Expenses [Abstract]
Research and Development Expense	149,472	154,435	486,204	464,891
Selling, general and administrative	76,269	82,003	275,836	265,791
Other operating expense	33,581	15,645	48,038	29,675
Total operating expenses	259,322	252,083	810,078	760,357
Operating income	8,729	296,010	372,150	955,472
Interest expense	(17,066)	(15,328)	(51,222)	(45,934)
Other income, net	5,562	2,532	2,714	24,077
(Loss) income before income taxes	(2,775)	283,214	323,642	933,615
Income tax expense	(13,156)	(66,951)	(82,074)	(112,537)
Net (loss) income	$ (15,931)	$ 216,263	$ 241,568	$ 821,078
Earnings Per Share [Abstract]
Basic	$ (0.16)	$ 1.97	$ 2.34	$ 7.40
Diluted	$ (0.16)	$ 1.95	$ 2.33	$ 7.30
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic	100,943	109,687	103,039	110,966
Diluted	100,943	110,810	103,812	112,415

XML

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Dec. 31, 2022	Jan. 01, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ (15,931)	$ 216,263	$ 241,568	$ 821,078
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment, including intra-entity foreign currency transactions that are of a long-term investment nature	30,403	(8,488)	(16,623)	(14,767)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax	0	(359)	0	(359)
Reclassification adjustments, net of tax:
Amortization of pension actuarial loss	8	29	26	90
Other comprehensive income (loss)	30,411	(8,818)	(16,597)	(15,036)
Total comprehensive income	$ 14,480	$ 207,445	$ 224,971	$ 806,042

XML

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Accumulated Other Comprehensive Loss	Retained Earnings
Common Stock, Shares, Outstanding		112,557
Common stock and additional paid-in capital	$ 4,244,740
Stockholders' Equity Attributable to Parent	4,629,425
Accumulated Other Comprehensive Income (Loss), Net of Tax	29,649
Retained Earnings (Accumulated Deficit)	355,036
Net income	821,078	$ 0	$ 0	$ 821,078
Other Comprehensive Income (Loss), Net of Tax	(15,036)	$ 0	(15,036)	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		683
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	(49,979)	$ (49,979)	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans		273
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 33,297	$ 33,297	0	0
Stock Repurchased During Period, Shares	(4,800)	(4,845)
Stock Repurchased During Period, Value	$ (825,393)	$ (182,767)	0	(642,626)
Stock-based compensation	73,807	$ 73,807	0	0
Payments for Repurchase of Common Stock	825,393
Common Stock, Shares, Outstanding		110,461
Common stock and additional paid-in capital	4,158,170
Stockholders' Equity Attributable to Parent	4,727,754
Accumulated Other Comprehensive Income (Loss), Net of Tax	23,431
Retained Earnings (Accumulated Deficit)	546,153
Net income	216,263	$ 0	0	216,263
Other Comprehensive Income (Loss), Net of Tax	(8,818)	$ 0	(8,818)	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		41
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	(527)	$ (527)	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans		108
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 15,503	$ 15,503	0
Stock Repurchased During Period, Shares	(1,900)	(1,942)
Stock Repurchased During Period, Value	$ (302,020)	$ (73,092)	0	(228,928)
Stock-based compensation	$ 19,044	$ 19,044	0	0
Common Stock, Shares, Outstanding	108,668	108,668
Common stock and additional paid-in capital	$ 4,119,098
Stockholders' Equity Attributable to Parent	4,667,199
Accumulated Other Comprehensive Income (Loss), Net of Tax	14,613
Retained Earnings (Accumulated Deficit)	$ 533,488
Common Stock, Shares, Outstanding	106,303
Common stock and additional paid-in capital	$ 4,035,849
Stockholders' Equity Attributable to Parent	4,553,218
Accumulated Other Comprehensive Income (Loss), Net of Tax	5,232
Retained Earnings (Accumulated Deficit)	512,137
Net income	241,568	$ 0	0	241,568
Other Comprehensive Income (Loss), Net of Tax	(16,597)	$ 0	(16,597)	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		550
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	(21,502)	$ (21,502)	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans		345
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 30,169	$ 30,169	0	0
Stock Repurchased During Period, Shares	(7,200)	(7,177)
Stock Repurchased During Period, Value	$ (711,732)	$ (274,020)	0	(437,712)
Stock-based compensation	89,444	$ 89,444	0	0
Payments for Repurchase of Common Stock	711,732
Common Stock, Shares, Outstanding		102,061
Common stock and additional paid-in capital	3,915,969
Stockholders' Equity Attributable to Parent	4,322,140
Accumulated Other Comprehensive Income (Loss), Net of Tax	(41,776)
Retained Earnings (Accumulated Deficit)	447,947
Net income	(15,931)	$ 0	0	(15,931)
Other Comprehensive Income (Loss), Net of Tax	30,411	$ 0	30,411	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		41
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	(321)	$ (321)	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans		150
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 11,276	$ 11,276	0	0
Stock Repurchased During Period, Shares	(2,200)	(2,231)
Stock Repurchased During Period, Value	$ (201,633)	$ (85,610)	0	(116,023)
Stock-based compensation	$ 18,626	$ 18,626	$ 0	$ 0
Common Stock, Shares, Outstanding	100,021
Common stock and additional paid-in capital	$ 3,859,940
Stockholders' Equity Attributable to Parent	4,164,568
Accumulated Other Comprehensive Income (Loss), Net of Tax	(11,365)
Retained Earnings (Accumulated Deficit)	$ 315,993

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2022	Jan. 01, 2022
Cash flows from operating activities:
Net income	$ 241,568	$ 821,078
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	155,132	159,038
Intangible assets amortization	99,476	112,523
Deferred income taxes	(2,557)	37,566
Stock-based compensation expense	86,911	73,236
Other, net	95,459	6,703
Changes in operating assets and liabilities:
Accounts receivable, net	201,823	(170,511)
Inventories	(98,882)	(190,247)
Prepaid expenses and other assets	42,979	(145,643)
Accounts payable and accrued liabilities	(85,321)	42,797
Income taxes payable and receivable	(17,281)	(16,303)
Other liabilities	58,481	(26,874)
Net cash provided by operating activities	777,788	703,363
Cash flows from investing activities:
Purchase of property and equipment	(124,853)	(162,993)
Purchase of businesses, net of cash acquired	95	389,192
Other investing activities	7,590	9
Net cash used in investing activities	(117,358)	(552,176)
Repayments of Long-term Debt	0	197,500
Proceeds from borrowings and debt issuances	0	499,070
Cash flows from financing activities:
Repurchase of common stock, including transaction costs	(711,732)	(825,393)
Proceeds from the issuance of common stock	20,828	26,653
Tax withholding paid on behalf of employees for restricted stock units	(22,687)	(52,265)
Other financing activities	(422)	(9,078)
Net cash used in financing activities	(714,013)	(558,513)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(280)	(2,063)
Net decrease in cash, cash equivalents and restricted cash	(53,863)	(409,389)
Cash, cash equivalents and restricted cash at the beginning of the period	972,805	1,398,309
Cash, cash equivalents and restricted cash at the end of the period	918,942	988,920
Cash and cash equivalents	918,758	988,527
Restricted cash included in "Other current assets" and "Other non-current assets"	184	393
Capital expenditures included in liabilities	$ 26,597	$ 42,055

XML

Basis of Presentation and Significant Accounting Policies

9 Months Ended

Dec. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

The accompanying Condensed Consolidated Financial Statements of Qorvo, Inc. and Subsidiaries (together, the "Company" or "Qorvo") have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP"). The preparation of these financial statements requires management to make estimates and assumptions, which could differ materially from actual results. In addition, certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). In the opinion of management, the financial statements include all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of the interim periods presented. These Condensed Consolidated Financial Statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto included in Qorvo’s Annual Report on Form 10-K for the fiscal year ended April 2, 2022.

The Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. During the second quarter of fiscal 2023, the Company updated its organizational structure to more closely align similar technologies and applications with customers and end markets. The Company manages its business and reports its financial results in three reportable segments: High Performance Analog ("HPA"), Connectivity and Sensors Group ("CSG") and Advanced Cellular Group ("ACG").

Certain items in the fiscal 2022 financial statements (including prior period segment results) have been reclassified to conform with the fiscal 2023 presentation.

The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. Each fiscal year, the first quarter ends on the Saturday closest to June 30, the second quarter ends on the Saturday closest to September 30 and the third quarter ends on the Saturday closest to December 31. Fiscal years 2023 and 2022 are 52-week years.

XML

Inventories

9 Months Ended

Dec. 31, 2022

Inventory Disclosure [Abstract]

INVENTORIES

INVENTORIES

The components of inventories, net of reserves, are as follows (in thousands):

	December 31, 2022		April 2, 2022
Raw materials	$	318,288	$	236,095
Work in process	350,122		357,332
Finished goods	188,867		162,321
Total inventories	$	857,277	$	755,748

XML

Business Acquisition

9 Months Ended

Dec. 31, 2022

Business Combinations [Abstract]

Business Combination Disclosure

BUSINESS ACQUISITIONS

United Silicon Carbide, Inc.

On October 19, 2021, the Company acquired all the outstanding equity interests of United Silicon Carbide, Inc. ("United SiC"), a leading manufacturer of silicon carbide ("SiC") power semiconductors, for a total purchase price of $236.7 million. The acquisition expanded the Company's offerings to include SiC power products for a range of applications, such as electric vehicles, battery charging, IT infrastructure, renewables and circuit protection.

The purchase price comprised cash consideration of $227.2 million and contingent consideration of up to $31.3 million which is expected to be paid to the sellers (in the first quarter of fiscal 2024) upon achieving certain revenue and gross margin targets over the period beginning on the acquisition date through December 31, 2022. The estimated fair value of the contingent consideration liability was $9.5 million as of the acquisition date. At April 2, 2022, the contingent consideration liability was remeasured to a fair value of $17.6 million and is included in "Other long-term liabilities" in the Condensed Consolidated Balance Sheet. At December 31, 2022, the maximum contingent consideration of $31.3 million was earned and is included in "Other current liabilities" in the Condensed Consolidated Balance Sheet, with the increase in fair value recognized in "Other operating expense" in the Condensed Consolidated Statement of Operations. Refer to Note 5 for further information related to the fair value measurement.

NextInput, Inc.

On April 5, 2021, the Company acquired all the outstanding equity interests of NextInput, Inc. ("NextInput"), a leader in microelectromechanical system ("MEMS")-based sensing solutions, for a total cash purchase price of $173.3 million. The acquisition expanded the Company's offerings of MEMS-based products for mobile applications, providing sensing solutions for a broad range of applications in other markets.

XML

Goodwill and Intangible Assets

9 Months Ended

Dec. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets Disclosure [Text Block]

GOODWILL AND INTANGIBLE ASSETS

During the second quarter of fiscal 2023, the Company updated its organizational structure (see Note 1).

The changes in the carrying amount of goodwill are as follows (in thousands):

	HPA		CSG		ACG		Total
Balance as of April 2, 2022 (1)	$	501,899	$	539,875	$	1,733,860	$	2,775,634
NextInput measurement period adjustments	—		572		—		572
United SiC measurement period adjustments	(297)		—		—		(297)
Effect of changes in foreign currency exchange rates	—		(5,763)		—		(5,763)
Balance as of December 31, 2022 (1)	$	501,602	$	534,684	$	1,733,860	$	2,770,146

(1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs totaling $669.6 million, which were recognized in fiscal years 2009, 2013, 2014 and 2022.

The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands):

	December 31, 2022				April 2, 2022
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Developed technology	$	866,916	$	352,141	$	1,026,690	$	420,255
Customer relationships	104,429		62,703		104,778		47,208
Technology licenses	1,411		405		2,641		2,169
Trade names	899		664		1,933		1,358
In-process research and development	9,633		N/A		9,734		N/A
Total (1)	$	983,288	$	415,913	$	1,145,776	$	470,990

(1) Amounts include the impact of foreign currency translation.

At the beginning of each fiscal year, the Company removes the gross asset and accumulated amortization amounts of intangible assets that have reached the end of their useful lives and have been fully amortized. Useful lives are estimated based on the expected economic benefit to be derived from the intangible assets.

XML

Investments and Fair Value of Financial Instruments

9 Months Ended

Dec. 31, 2022

Investments and Fair Value Measurements [Abstract]

INVESTMENTS AND FAIR VALUE MEASUREMENTS

INVESTMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS

Equity Method Investments

The Company invests in limited partnerships and accounts for these investments using the equity method. The carrying amounts of these investments, as of December 31, 2022 and April 2, 2022, were $20.2 million and $27.1 million, respectively, and are classified as "Long-term investments" in the Condensed Consolidated Balance Sheets. During the three and nine months ended December 31, 2022, the Company recorded a loss of $5.0 million and $4.7 million, respectively, based on its share of the limited partnerships' earnings. During the three and nine months ended January 1, 2022, the Company recorded a loss of $2.4 million and income of $13.6 million, respectively, based on its share of the limited partnerships' earnings. These amounts are included in "Other income, net" in the Condensed Consolidated Statements of Operations. During the three and

nine months ended December 31, 2022, the Company received cash distributions of $0.2 million and $2.2 million, respectively, from these limited partnerships. No cash distributions were received during the three months ended January 1, 2022 and $13.5 million of cash distributions were received during the nine months ended January 1, 2022. The cash distributions were recognized as reductions to the carrying value of the investments and included in the cash flows from investing activities in the Condensed Consolidated Statements of Cash Flows.

Fair Value of Financial Instruments

The fair value of the financial assets and liabilities measured on a recurring basis was determined using the following levels of inputs (in thousands):

	Total		Quoted Prices In Active Markets For Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
December 31, 2022
Marketable equity securities	$	1,121	$	1,121	$	—	$	—
Invested funds in deferred compensation plan (1)	37,687		37,687		—		—
Contingent earn-out liability (2)	(31,250)		—		—		(31,250)
April 2, 2022
Marketable equity securities	$	2,906	$	2,906	$	—	$	—
Invested funds in deferred compensation plan (1)	39,356		39,356		—		—
Contingent earn-out liability (2)	(17,600)		—		—		(17,600)

(1) Invested funds under the Company's non-qualified deferred compensation plan are held in a rabbi trust and consist of mutual funds. The fair value of the mutual funds is calculated using the net asset value per share determined by quoted active market prices of the underlying investments.

(2) At December 31, 2022, the maximum contingent consideration was recorded related to the acquisition of United SiC (refer to Note 3). At April 2, 2022, the fair value of this liability was estimated using an option pricing model.

XML

Long-Term Debt

9 Months Ended

Dec. 31, 2022

Debt Disclosure [Abstract]

DEBT

LONG-TERM DEBT

Long-term debt is as follows (in thousands):

	December 31, 2022		April 2, 2022
1.750% senior notes due 2024	$	500,000	$	500,000
4.375% senior notes due 2029	850,000		850,000
3.375% senior notes due 2031	700,000		700,000
Finance leases and other	1,839		2,581
Unamortized premium, discount and issuance costs, net	(3,645)		(4,692)
Less current portion of long-term debt	(451)		(791)
Total long-term debt	$	2,047,743	$	2,047,098

Credit Agreement

On September 29, 2020, the Company and certain of its U.S. subsidiaries (the "Guarantors") entered into a five-year unsecured senior credit facility pursuant to a credit agreement (as amended, restated, modified or otherwise supplemented from time to time, the "Credit Agreement") with Bank of America, N.A., acting as administrative agent, and a syndicate of lenders. The Credit Agreement amended and restated the previous credit agreement dated as of December 5, 2017. The Credit Agreement includes a senior revolving line of credit (the "Revolving Facility") of up to $300.0 million, and included a senior term loan of $200.0 million (collectively, the "Credit Facility"), that was fully repaid in fiscal 2022.

On April 6, 2022, the Company and the administrative agent entered into an amendment to the Credit Agreement (the "LIBOR Transition Amendment") to replace the London Interbank Offered Rate as a reference rate available for use in the computation of interest under the Credit Agreement. As a result of the LIBOR Transition Amendment, at the Company’s option, loans under the Credit Agreement will bear interest at (i) the Applicable Rate (as defined in the Credit Agreement) plus the Term SOFR (as defined in the Credit Agreement) or (ii) the Applicable Rate plus a rate equal to the highest of (a) the federal funds rate plus 0.50%, (b) the prime rate as set by the administrative agent, and (c) the Term SOFR plus 1.0% (the "Base Rate"). All swing line loans will bear interest at a rate equal to the Applicable Rate plus the Base Rate. The Term SOFR is the rate per annum equal to the forward-looking Secured Overnight Financing Rate term rate for interest periods of one, three or six months (as selected by the Company) plus an adjustment (as defined in the Credit Agreement). The Applicable Rate for Term SOFR loans ranges from 1.000% per annum to 1.250% per annum, and the Applicable Rate for Base Rate loans ranges from 0.000% per annum to 0.250% per annum. Undrawn amounts under the Credit Facility are subject to a commitment fee ranging from 0.150% to 0.200%.

During the three and nine months ended December 31, 2022, there were no borrowings under the Revolving Facility.

Senior Notes due 2024

On December 14, 2021, the Company issued $500.0 million aggregate principal amount of its 1.750% senior notes due 2024 (the "2024 Notes"). The 2024 Notes will mature on December 15, 2024, unless earlier redeemed in accordance with their terms. The 2024 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

The 2024 Notes were issued pursuant to an indenture, dated as of December 14, 2021 (the "2021 Indenture"), by and among the Company, the Guarantors and Computershare Trust Company, N.A., as trustee. The 2021 Indenture contains customary events of default, including payment default, exchange default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events. The 2021 Indenture also contains customary negative covenants.

Interest is payable on the 2024 Notes on June 15 and December 15 of each year. The Company paid interest of $4.4 million and $8.8 million on the 2024 Notes during the three and nine months ended December 31, 2022, respectively.

Senior Notes due 2029

On September 30, 2019, the Company issued $350.0 million aggregate principal amount of its 4.375% senior notes due 2029 (the "Initial 2029 Notes"). On December 20, 2019, and June 11, 2020, the Company issued an additional $200.0 million and $300.0 million, respectively, aggregate principal amount of such notes (together, the "Additional 2029 Notes" and together with the Initial 2029 Notes, the "2029 Notes"). The 2029 Notes will mature on October 15, 2029, unless earlier redeemed in accordance with their terms. The 2029 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

The Initial 2029 Notes were issued pursuant to an indenture, dated as of September 30, 2019, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee, and the Additional 2029 Notes were issued pursuant to supplemental indentures, dated as of December 20, 2019, and June 11, 2020 (such indenture and supplemental indentures, collectively, the "2019 Indenture"). The 2019 Indenture contains substantially the same customary events of default and negative covenants as the 2021 Indenture.

Interest is payable on the 2029 Notes on April 15 and October 15 of each year. The Company paid interest of $18.6 million on the 2029 Notes during the three months ended December 31, 2022 and January 1, 2022, and paid interest of $37.2 million during the nine months ended December 31, 2022 and January 1, 2022.

Senior Notes due 2031

On September 29, 2020, the Company issued $700.0 million aggregate principal amount of its 3.375% senior notes due 2031 (the "2031 Notes"). The 2031 Notes will mature on April 1, 2031, unless earlier redeemed in accordance with their terms. The 2031 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

The 2031 Notes were issued pursuant to an indenture, dated as of September 29, 2020, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee (the "2020 Indenture"). The 2020 Indenture contains substantially the same customary events of default and negative covenants as the 2021 Indenture.

Interest is payable on the 2031 Notes on April 1 and October 1 of each year. The Company paid no interest on the 2031 Notes during the three months ended December 31, 2022 and January 1, 2022, and paid interest of $11.8 million during the nine months ended December 31, 2022 and January 1, 2022.

Fair Value of Long-Term Debt

The Company's debt is carried at amortized cost and is measured quarterly at fair value for disclosure purposes. The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of December 31, 2022 was $459.8 million, $777.8 million and $572.3 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of April 2, 2022 was $476.9 million, $852.6 million and $638.6 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The Company considers its debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2024 Notes, the 2029 Notes and the 2031 Notes currently trade over-the-counter, and the fair values were estimated based upon the value of the last trade at the end of the period.

Interest Expense

During the three and nine months ended December 31, 2022, the Company recognized total interest expense of $18.1 million and $54.2 million, respectively, primarily related to the 2024 Notes, the 2029 Notes and the 2031 Notes, partially offset by interest capitalized to property and equipment of $1.0 million and $3.0 million, respectively. During the three and nine months ended January 1, 2022, the Company recognized total interest expense of $16.3 million and $48.7 million, respectively, primarily related to the 2029 Notes and the 2031 Notes, partially offset by interest capitalized to property and equipment of $0.9 million and $2.8 million, respectively.

XML

Stock Repurchases

9 Months Ended

Dec. 31, 2022

Equity [Abstract]

STOCK REPURCHASES

7. STOCK REPURCHASES

On November 2, 2022, the Company announced that its Board of Directors authorized a new share repurchase program to repurchase up to $2.0 billion of the Company's outstanding common stock, which included the remaining authorized dollar amount under a prior program terminated concurrent with the new authorization. Under the current program, share repurchases are made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which the Company repurchases its shares, the number of shares and the timing of any repurchases depends on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require the Company to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended, or terminated at any time without prior notice.

During the three and nine months ended December 31, 2022, the Company repurchased approximately 2.2 million and 7.2 million shares of its common stock for approximately $201.6 million and $711.7 million, respectively (including transaction costs) under the prior and current share repurchase programs. As of December 31, 2022, approximately $1,855.0 million remains available for repurchases under the current share repurchase program.

During the three and nine months ended January 1, 2022, the Company repurchased approximately 1.9 million and 4.8 million shares, respectively, of its common stock for approximately $302.0 million and $825.4 million, respectively (including transaction costs).

XML

Commitments and Contingent Liabilities

9 Months Ended

Dec. 31, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

COMMITMENTS AND CONTINGENT LIABILITIES

Purchase Obligations

Amidst ongoing industry-wide supply constraints, the Company entered into a long-term capacity reservation agreement with a foundry supplier during the second quarter of fiscal 2022. Under this agreement, the Company was required to purchase, and

the foundry supplier was required to supply, a certain number of wafers (at predetermined sales prices) for calendar years 2022 through 2025. In connection with this agreement, the Company paid a refundable deposit (which was recorded in "Other non-current assets" in the Condensed Consolidated Balance Sheets), and if the purchase commitments per the agreement were not met, under certain circumstances the supplier could deduct the amount of the purchase shortfall from the prepaid refundable deposit at the end of each calendar year.

During fiscal 2023, the Company has experienced unexpectedly weakened demand for 5G handsets in China and EMEA primarily due to unprecedented disruption resulting from measures taken in China to control the COVID-19 pandemic and the conflict in Ukraine. As a result, the Company did not meet the minimum purchase commitments under this long-term capacity reservation agreement.

In the first quarter of fiscal 2023, the purchase shortfall resulted in an impairment to the prepaid refundable deposit of approximately $13.0 million and additional reserves of approximately $11.0 million for inventory in excess of demand forecasts were recorded. Additionally, the Company assessed the future minimum purchase commitments over the remaining term of the agreement and recorded an estimated shortfall of $86.0 million, of which $8.0 million was recorded in "Other current liabilities" and $78.0 million was recorded in "Other long-term liabilities" in accordance with Accounting Standards Codification ("ASC") 330, "Inventory." These transactions resulted in a total increase to cost of goods sold of $110.0 million in the first quarter of fiscal 2023.

In October 2022, the Company renegotiated the terms of the agreement with the foundry supplier, which included extending the duration of the agreement through calendar year 2026. The Company believes that the amended agreement more closely aligns the contractual purchase commitments with forecasted demand. As a result of the amended agreement, in the second quarter of fiscal 2023, the Company recorded an impairment to the prepaid refundable deposit of approximately $38.0 million and additional reserves of approximately $5.0 million for inventory in excess of demand forecasts, which reduced the estimated shortfall liability that was previously recorded by $43.0 million. In the third quarter of fiscal 2023, the Company recorded an impairment to the prepaid refundable deposit of approximately $8.0 million and additional reserves of approximately $4.0 million for inventory in excess of demand forecasts, which reduced the estimated shortfall liability that was previously recorded by $12.0 million. There was no impact to the statements of operations in the second or third quarters of fiscal 2023. There were no material changes to the Company's estimated future purchase obligations under the current terms of the capacity reservation agreement during the current quarter.

In performing these assessments, the Company considered Company-specific forecasts, legal obligations, macroeconomic and geopolitical factors as well as market and industry trends. These factors include significant management judgment and estimates and, to the extent that these assumptions are incorrect or there are further declines in management's demand forecasts, additional charges may be recorded in future periods.

Legal Matters

The Company is involved in various legal proceedings and claims that have arisen in the ordinary course of business that have not been fully adjudicated. The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company regularly evaluates developments in its legal matters that could affect the amount of the previously accrued liability and records adjustments as appropriate. Although it is not possible to predict with certainty the outcome of the unresolved legal matters, it is the opinion of management that these matters will not, individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position or results of operations. The aggregate range of reasonably possible losses in excess of accrued liabilities, if any, associated with these unresolved legal matters is not material.

XML

Revenue

9 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

REVENUE

REVENUE

The following table presents the Company's revenue disaggregated by geography, based on the location of the customers' headquarters (in thousands):

	Three Months Ended				Nine Months Ended
	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
United States	$	459,194	$	569,494	$	1,470,231	$	1,449,667
China	124,799		273,582		630,012		1,227,782
Other Asia	72,002		136,089		390,690		364,855
Taiwan	53,072		76,432		274,707		253,713
Europe	34,214		58,360		171,056		183,539
Total revenue	$	743,281	$	1,113,957	$	2,936,696	$	3,479,556

The Company also disaggregates revenue by operating segments (refer to Note 11).

XML

Restructuring and Related Activities

9 Months Ended

Dec. 31, 2022

Restructuring and Related Activities [Abstract]

RESTRUCTURING

RESTRUCTURING

In fiscal 2023, the Company has taken actions to improve efficiencies in its operations and further align the organization with its strategic objectives.  The Company will continue to evaluate its operating footprint, cost structure and strategic opportunities.

The following table summarizes the charges resulting from the restructuring actions (in thousands):

	Three Months Ended December 31, 2022						Nine Months Ended December 31, 2022
	Cost of Goods Sold		Other Operating Expense		Total		Cost of Goods Sold		Other Operating Expense		Total
Contract termination and other costs	$	3,600	$	11,509	$	15,109	$	3,600	$	13,433	$	17,033
Asset impairment costs (1)	—		12,899		12,899		—		12,899		12,899
One-time employee termination benefits (2)	—		(623)		(623)		—		2,547		2,547
Total	$	3,600	$	23,785	$	27,385	$	3,600	$	28,879	$	32,479

(1) Relates to the adjustment of certain property and equipment to reflect its fair value.

(2) Includes reversal due to adjustment of previously accrued restructuring charges.

The following table summarizes the activity related to the Company's restructuring liabilities for the nine months ended December 31, 2022 (in thousands):

	One-Time Employee Termination Benefits		Contract Termination and Other Costs		Total
Accrued restructuring balance as of April 2, 2022	$	—	$	—	$	—
Costs incurred and charged to expense	2,547		17,033		19,580
Cash payments	(2,022)		(967)		(2,989)
Accrued restructuring balance as of December 31, 2022	$	525	$	16,066	$	16,591

XML

Operating Segment Information

9 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

OPERATING SEGMENT INFORMATION

OPERATING SEGMENT INFORMATION

In the second quarter of fiscal 2023, the Company updated its organizational structure from two operating segments (Mobile Products and Infrastructure and Defense Products) to three operating segments (High Performance Analog ("HPA"), Connectivity and Sensors Group ("CSG") and Advanced Cellular Group ("ACG")). This change was made to more closely align similar technologies and applications with customers and end markets, which represents how the Company currently manages its three operating segments (which are also its reportable segments). The Company's Chief Executive Officer, who is also the Company's chief operating decision maker ("CODM"), allocates resources and evaluates the performance of each of the three operating segments primarily based on operating income. All prior-period segment data has been retrospectively adjusted to reflect these three operating segments.

HPA is a leading global supplier of RF and power management solutions for infrastructure, defense and aerospace, automotive power and other markets. HPA leverages a diverse portfolio of differentiated technologies and products to support multiyear growth trends, including electrification, renewable energy, the increasing semiconductor spend in defense and 5G deployments outside of China.

CSG is a leading global supplier of connectivity and sensor components and systems featuring multiple technologies such as UWB, Matter®, Bluetooth® Low Energy, Zigbee®, Thread®, Wi-Fi®, cellular IoT and MEMS-/BAW-based sensors. CSG combines the connectivity and sensors businesses formerly split between Mobile Products and Infrastructure and Defense Products. CSG’s markets include smart home, automotive connectivity, industrial automation, smartphones, wearables, gaming and other high-growth IoT connectivity and healthcare markets.

ACG is a leading global supplier of cellular RF solutions for smartphones, wearables, laptops, tablets and various other devices. ACG leverages world-class technology and systems-level expertise to deliver a broad portfolio of high performance cellular products to the world's leading smartphone and consumer electronics companies. ACG is a highly diversified supplier of custom and open market cellular solutions, serving iOS and Android original equipment manufacturers.

The "All other" category includes operating expenses such as stock-based compensation expense, amortization of intangible assets, restructuring related charges, acquisition and integration related costs, charges associated with a long-term capacity reservation agreement, fixed asset impairments, gain (loss) on sale of fixed assets, start-up costs and other miscellaneous corporate overhead expenses that the Company does not allocate to its reportable segments because these expenses are not included in the segment operating performance measures evaluated by the Company’s CODM. The CODM does not evaluate operating segments using discrete asset information. The Company’s operating segments do not record intercompany revenue. The Company does not allocate gains and losses from investments, interest expense, other (expense) income, or taxes to operating segments. Except as discussed above regarding the "All other" category, the Company’s accounting policies for segment reporting are the same as for the Company as a whole.

The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands):

	Three Months Ended				Nine Months Ended
	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Revenue:
HPA	$	155,011	$	181,876	$	594,094	$	496,842
CSG	96,810		157,578		392,454		525,190
ACG	491,460		774,503		1,950,148		2,457,524
Total revenue	$	743,281	$	1,113,957	$	2,936,696	$	3,479,556
Operating income (loss):
HPA	$	29,836	$	56,951	$	181,102	$	140,953
CSG	(31,145)		21,109		(29,926)		77,287
ACG	99,862		293,948		569,439		956,215
All other	(89,824)		(75,998)		(348,465)		(218,983)
Operating income	8,729		296,010		372,150		955,472
Interest expense	(17,066)		(15,328)		(51,222)		(45,934)
Other income, net	5,562		2,532		2,714		24,077
(Loss) income before income taxes	$	(2,775)	$	283,214	$	323,642	$	933,615

	Three Months Ended				Nine Months Ended
	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Reconciliation of "All other" category:
Stock-based compensation expense	$	(19,708)	$	(19,307)	$	(86,911)	$	(73,236)
Amortization of intangible assets	(32,844)		(38,443)		(99,283)		(112,243)
Restructuring related charges (1)	(27,385)		—		(32,479)		—
Acquisition and integration related costs	(6,296)		(6,552)		(21,246)		(16,585)
Charges associated with a long-term capacity reservation agreement (2)	—		—		(110,000)		—
Other	(3,591)		(11,696)		1,454		(16,919)
Loss from operations for "All other"	$	(89,824)	$	(75,998)	$	(348,465)	$	(218,983)

(1) Refer to Note 10 for additional information.

(2) Refer to Note 8 for additional information.

XML

Income Taxes

9 Months Ended

Dec. 31, 2022

Income Tax Disclosure [Abstract]

INCOME TAXES

INCOME TAXES

The Company’s income tax expense was $13.2 million and $82.1 million for the three and nine months ended December 31, 2022, respectively, and $67.0 million and $112.5 million, for the three and nine months ended January 1, 2022, respectively. The Company’s effective tax rate was (474.1)% and 25.4% for the three and nine months ended December 31, 2022, respectively, and 23.6% and 12.1% for the three and nine months ended January 1, 2022, respectively.

The Company's effective tax rate for the three and nine months ended December 31, 2022 differed from the statutory rate primarily due to tax rate differences in foreign jurisdictions, global intangible low tax income ("GILTI"), domestic tax credits generated and discrete tax items recorded during the period. A discrete tax expense of $2.2 million and a discrete tax benefit of $10.4 million was recorded for the three and nine months ended December 31, 2022. The discrete tax expense for the three months ended December 31, 2022 primarily resulted from foreign currency gains recognized for tax purposes. The discrete tax benefit for the nine months ended December 31, 2022 primarily resulted from certain charges associated with a long-term

capacity reservation agreement (refer to Note 8 for further information), partially offset by foreign currency gains recognized for tax purposes.

The Company's effective tax rate for the three and nine months ended January 1, 2022 differed from the statutory rate primarily due to tax rate differences in foreign jurisdictions, GILTI, domestic tax credits and discrete tax items recorded during the period. A discrete tax expense of $42.5 million and $12.0 million was recorded during the three and nine months ended January 1, 2022, respectively. The discrete tax expense for the three and nine months ended January 1, 2022 primarily related to the revaluation of deferred tax assets due to the extension of the Company’s tax holiday in Singapore. The discrete tax expense for the nine months ended January 1, 2022 was partially offset by the recognition of previously unrecognized tax benefits due to the expiration of the statute of limitations, stock-based compensation deductions and net tax benefits associated with other non-recurring restructuring activities, including a discrete charge associated with the intercompany restructuring of the NextInput intellectual property.

XML

Net Income Per Share

9 Months Ended

Dec. 31, 2022

Earnings Per Share [Abstract]

NET INCOME PER SHARE

NET (LOSS) INCOME PER SHARE

The following table sets forth the computation of basic and diluted net (loss) income per share (in thousands, except per share data):

	Three Months Ended				Nine Months Ended
	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Numerator:
Numerator for basic and diluted net (loss) income per share — net (loss) income available to common stockholders	$	(15,931)	$	216,263	$	241,568	$	821,078
Denominator:
Denominator for basic net (loss) income per share — weighted average shares	100,943		109,687		103,039		110,966
Effect of dilutive securities:
Stock-based awards	—		1,123		773		1,449
Denominator for diluted net (loss) income per share — adjusted weighted average shares and assumed conversions	100,943		110,810		103,812		112,415
Basic net (loss) income per share	$	(0.16)	$	1.97	$	2.34	$	7.40
Diluted net (loss) income per share	$	(0.16)	$	1.95	$	2.33	$	7.30

In the computation of net loss per share for the three months ended December 31, 2022, approximately 2.0 million shares of outstanding stock-based awards were excluded because the effect of their inclusion would have been anti-dilutive. In the computation of diluted net income per share for the nine months ended December 31, 2022, approximately 0.9 million shares of outstanding stock-based awards were excluded because the effect of their inclusion would have been anti-dilutive. An immaterial number of shares of outstanding stock-based awards were excluded from the computation of diluted net income per share for the three and nine months ended January 1, 2022 because the effect of their inclusion would have been anti-dilutive.

XML

Long-Term Debt Fair Value of Debt (Policies)	9 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Fair value of debt [Policy Text Block]	The Company's debt is carried at amortized cost and is measured quarterly at fair value for disclosure purposes. The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of December 31, 2022 was $459.8 million, $777.8 million and $572.3 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of April 2, 2022 was $476.9 million, $852.6 million and $638.6 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The Company considers its debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2024 Notes, the 2029 Notes and the 2031 Notes currently trade over-the-counter, and the fair values were estimated based upon the value of the last trade at the end of the period.

XML

Operating Segment Information Segment Policy (Policies)	9 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Segment Reporting, Policy [Policy Text Block]	In the second quarter of fiscal 2023, the Company updated its organizational structure from two operating segments (Mobile Products and Infrastructure and Defense Products) to three operating segments (High Performance Analog ("HPA"), Connectivity and Sensors Group ("CSG") and Advanced Cellular Group ("ACG")). This change was made to more closely align similar technologies and applications with customers and end markets, which represents how the Company currently manages its three operating segments (which are also its reportable segments). The Company's Chief Executive Officer, who is also the Company's chief operating decision maker ("CODM"), allocates resources and evaluates the performance of each of the three operating segments primarily based on operating income. All prior-period segment data has been retrospectively adjusted to reflect these three operating segments.

XML

Inventories (Tables)

9 Months Ended

Dec. 31, 2022

Inventory Disclosure [Abstract]

Components of inventories

The components of inventories, net of reserves, are as follows (in thousands):

	December 31, 2022		April 2, 2022
Raw materials	$	318,288	$	236,095
Work in process	350,122		357,332
Finished goods	188,867		162,321
Total inventories	$	857,277	$	755,748

XML

Goodwill and Intangible Assets (Tables)

9 Months Ended

Dec. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill [Table Text Block]

The changes in the carrying amount of goodwill are as follows (in thousands):

	HPA		CSG		ACG		Total
Balance as of April 2, 2022 (1)	$	501,899	$	539,875	$	1,733,860	$	2,775,634
NextInput measurement period adjustments	—		572		—		572
United SiC measurement period adjustments	(297)		—		—		(297)
Effect of changes in foreign currency exchange rates	—		(5,763)		—		(5,763)
Balance as of December 31, 2022 (1)	$	501,602	$	534,684	$	1,733,860	$	2,770,146

(1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs totaling $669.6 million, which were recognized in fiscal years 2009, 2013, 2014 and 2022.

Schedule of finite-lived and indefinite-lived intangible assets [Table Text Block]

The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands):

	December 31, 2022				April 2, 2022
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Developed technology	$	866,916	$	352,141	$	1,026,690	$	420,255
Customer relationships	104,429		62,703		104,778		47,208
Technology licenses	1,411		405		2,641		2,169
Trade names	899		664		1,933		1,358
In-process research and development	9,633		N/A		9,734		N/A
Total (1)	$	983,288	$	415,913	$	1,145,776	$	470,990

(1) Amounts include the impact of foreign currency translation.

XML

Investments and Fair Value of Financial Instruments (Tables)

9 Months Ended

Dec. 31, 2022

Investments and Fair Value Measurements [Abstract]

Fair value of the financial assets measured at fair value on a recurring basis

The fair value of the financial assets and liabilities measured on a recurring basis was determined using the following levels of inputs (in thousands):

	Total		Quoted Prices In Active Markets For Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
December 31, 2022
Marketable equity securities	$	1,121	$	1,121	$	—	$	—
Invested funds in deferred compensation plan (1)	37,687		37,687		—		—
Contingent earn-out liability (2)	(31,250)		—		—		(31,250)
April 2, 2022
Marketable equity securities	$	2,906	$	2,906	$	—	$	—
Invested funds in deferred compensation plan (1)	39,356		39,356		—		—
Contingent earn-out liability (2)	(17,600)		—		—		(17,600)

(1) Invested funds under the Company's non-qualified deferred compensation plan are held in a rabbi trust and consist of mutual funds. The fair value of the mutual funds is calculated using the net asset value per share determined by quoted active market prices of the underlying investments.

(2) At December 31, 2022, the maximum contingent consideration was recorded related to the acquisition of United SiC (refer to Note 3). At April 2, 2022, the fair value of this liability was estimated using an option pricing model.

XML

Debt (Tables)

9 Months Ended

Dec. 31, 2022

Debt Disclosure [Abstract]

Schedule of Long-term Debt Instruments

Long-term debt is as follows (in thousands):

	December 31, 2022		April 2, 2022
1.750% senior notes due 2024	$	500,000	$	500,000
4.375% senior notes due 2029	850,000		850,000
3.375% senior notes due 2031	700,000		700,000
Finance leases and other	1,839		2,581
Unamortized premium, discount and issuance costs, net	(3,645)		(4,692)
Less current portion of long-term debt	(451)		(791)
Total long-term debt	$	2,047,743	$	2,047,098

XML

Revenue (Tables)

9 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table presents the Company's revenue disaggregated by geography, based on the location of the customers' headquarters (in thousands):

	Three Months Ended				Nine Months Ended
	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
United States	$	459,194	$	569,494	$	1,470,231	$	1,449,667
China	124,799		273,582		630,012		1,227,782
Other Asia	72,002		136,089		390,690		364,855
Taiwan	53,072		76,432		274,707		253,713
Europe	34,214		58,360		171,056		183,539
Total revenue	$	743,281	$	1,113,957	$	2,936,696	$	3,479,556

XML

Restructuring and Related Activities (Tables)

9 Months Ended

Dec. 31, 2022

Restructuring and Related Activities [Abstract]

Schedule of restructuring activity

The following table summarizes the charges resulting from the restructuring actions (in thousands):

	Three Months Ended December 31, 2022						Nine Months Ended December 31, 2022
	Cost of Goods Sold		Other Operating Expense		Total		Cost of Goods Sold		Other Operating Expense		Total
Contract termination and other costs	$	3,600	$	11,509	$	15,109	$	3,600	$	13,433	$	17,033
Asset impairment costs (1)	—		12,899		12,899		—		12,899		12,899
One-time employee termination benefits (2)	—		(623)		(623)		—		2,547		2,547
Total	$	3,600	$	23,785	$	27,385	$	3,600	$	28,879	$	32,479

(1) Relates to the adjustment of certain property and equipment to reflect its fair value.

(2) Includes reversal due to adjustment of previously accrued restructuring charges.

Restructuring Liabilities Rollforward

The following table summarizes the activity related to the Company's restructuring liabilities for the nine months ended December 31, 2022 (in thousands):

	One-Time Employee Termination Benefits		Contract Termination and Other Costs		Total
Accrued restructuring balance as of April 2, 2022	$	—	$	—	$	—
Costs incurred and charged to expense	2,547		17,033		19,580
Cash payments	(2,022)		(967)		(2,989)
Accrued restructuring balance as of December 31, 2022	$	525	$	16,066	$	16,591

XML

Operating Segment Information (Tables)

9 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

Summary of details of reportable segments

The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands):

	Three Months Ended				Nine Months Ended
	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Revenue:
HPA	$	155,011	$	181,876	$	594,094	$	496,842
CSG	96,810		157,578		392,454		525,190
ACG	491,460		774,503		1,950,148		2,457,524
Total revenue	$	743,281	$	1,113,957	$	2,936,696	$	3,479,556
Operating income (loss):
HPA	$	29,836	$	56,951	$	181,102	$	140,953
CSG	(31,145)		21,109		(29,926)		77,287
ACG	99,862		293,948		569,439		956,215
All other	(89,824)		(75,998)		(348,465)		(218,983)
Operating income	8,729		296,010		372,150		955,472
Interest expense	(17,066)		(15,328)		(51,222)		(45,934)
Other income, net	5,562		2,532		2,714		24,077
(Loss) income before income taxes	$	(2,775)	$	283,214	$	323,642	$	933,615

Summary of reconciliation of "All other" category

	Three Months Ended				Nine Months Ended
	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Reconciliation of "All other" category:
Stock-based compensation expense	$	(19,708)	$	(19,307)	$	(86,911)	$	(73,236)
Amortization of intangible assets	(32,844)		(38,443)		(99,283)		(112,243)
Restructuring related charges (1)	(27,385)		—		(32,479)		—
Acquisition and integration related costs	(6,296)		(6,552)		(21,246)		(16,585)
Charges associated with a long-term capacity reservation agreement (2)	—		—		(110,000)		—
Other	(3,591)		(11,696)		1,454		(16,919)
Loss from operations for "All other"	$	(89,824)	$	(75,998)	$	(348,465)	$	(218,983)

(1) Refer to Note 10 for additional information.

(2) Refer to Note 8 for additional information.

XML

Net Income Per Share (Tables)

9 Months Ended

Dec. 31, 2022

Earnings Per Share [Abstract]

Reconciliation of the numerators and denominators in the computation of basic and diluted net loss per share

The following table sets forth the computation of basic and diluted net (loss) income per share (in thousands, except per share data):

	Three Months Ended				Nine Months Ended
	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Numerator:
Numerator for basic and diluted net (loss) income per share — net (loss) income available to common stockholders	$	(15,931)	$	216,263	$	241,568	$	821,078
Denominator:
Denominator for basic net (loss) income per share — weighted average shares	100,943		109,687		103,039		110,966
Effect of dilutive securities:
Stock-based awards	—		1,123		773		1,449
Denominator for diluted net (loss) income per share — adjusted weighted average shares and assumed conversions	100,943		110,810		103,812		112,415
Basic net (loss) income per share	$	(0.16)	$	1.97	$	2.34	$	7.40
Diluted net (loss) income per share	$	(0.16)	$	1.95	$	2.33	$	7.30

XML

Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Apr. 02, 2022
Components of inventories
Raw materials	$ 318,288	$ 236,095
Work in process	350,122	357,332
Finished goods	188,867	162,321
Total inventories	$ 857,277	$ 755,748

XML

Business Acquisition Narrative (Details) - USD ($) $ in Thousands			9 Months Ended
	Oct. 19, 2021	Apr. 05, 2021	Dec. 31, 2022	Jan. 01, 2022	Apr. 02, 2022
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired			$ 95	$ 389,192
Goodwill			2,770,146		$ 2,775,634
NextInput
Business Acquisition [Line Items]
Business Combination, Consideration Transferred		$ 173,300
Goodwill, Purchase Accounting Adjustments			572
United Silicon Carbide
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$ 227,200
Business Combination, Consideration Transferred	236,700
Goodwill, Purchase Accounting Adjustments			(297)
Business Combination, Contingent Consideration, Liability, Noncurrent	9,500		$ 31,300		$ 17,600
United Silicon Carbide | Maximum [Member]
Business Acquisition [Line Items]
Business Combination, Contingent Consideration, Liability	$ 31,300

XML

Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Apr. 02, 2022
Goodwill and Intangible Assets [Line Items]
Intangible assets amortization	$ 99,476	$ 112,523
Goodwill	2,770,146		$ 2,775,634
Goodwill, Accumulated impairment losses and write-offs	669,600		669,600
Accumulated Amortization	415,913		470,990
Goodwill, Foreign Currency Translation Gain (Loss)	(5,763)
Gross Carrying Amount	983,288		1,145,776
Technology licenses
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	1,411		2,641
Accumulated Amortization	405		2,169
Trade Names
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	899		1,933
Accumulated Amortization	664		1,358
Developed Technology
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	866,916		1,026,690
Accumulated Amortization	352,141		420,255
Customer Relationships
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	104,429		104,778
Accumulated Amortization	62,703		47,208
In-process research and development
Goodwill and Intangible Assets [Line Items]
IPRD	9,633		9,734
HPA
Goodwill and Intangible Assets [Line Items]
Goodwill	501,602		501,899
Goodwill, Foreign Currency Translation Gain (Loss)	0
CSG
Goodwill and Intangible Assets [Line Items]
Goodwill	534,684		539,875
Goodwill, Foreign Currency Translation Gain (Loss)	(5,763)
ACG
Goodwill and Intangible Assets [Line Items]
Goodwill	1,733,860		$ 1,733,860
Goodwill, Foreign Currency Translation Gain (Loss)	0
NextInput
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments	572
NextInput | HPA
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments	0
NextInput | CSG
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments	572
NextInput | ACG
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments	0
United Silicon Carbide
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments	(297)
United Silicon Carbide | HPA
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments	(297)
United Silicon Carbide | CSG
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments	0
United Silicon Carbide | ACG
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments	$ 0

XML

Investments and Fair Value of Financial Instruments (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Dec. 31, 2022	Jan. 01, 2022	Apr. 02, 2022	Oct. 19, 2021
Investments and Fair Value of Financial Instruments
Document Period End Date			Dec. 31, 2022
Equity Method Investments	$ 20,200,000		$ 20,200,000		$ 27,100,000
Proceeds from Limited Partnership Investments	200,000	$ 0	2,200,000	$ 13,500,000
Gain (Loss) on Investments	5,000,000	$ 2,400,000	4,700,000	$ 13,600,000
United Silicon Carbide
Investments and Fair Value of Financial Instruments
Business Combination, Contingent Consideration, Liability, Noncurrent	(31,300,000)		(31,300,000)		(17,600,000)	$ (9,500,000)
Fair Value, Recurring [Member] | United Silicon Carbide
Investments and Fair Value of Financial Instruments
Business Combination, Contingent Consideration, Liability, Noncurrent	(31,250,000)		(31,250,000)		(17,600,000)
Fair Value, Recurring [Member] | Equity Securities
Investments and Fair Value of Financial Instruments
Marketable Securities	1,121,000		1,121,000		2,906,000
Fair Value, Recurring [Member] | Mutual Fund
Investments and Fair Value of Financial Instruments
Deferred Compensation Plan Assets	37,687,000		37,687,000		39,356,000
Quoted Prices In Active Markets For Identical Assets (Level 1) | Fair Value, Recurring [Member] | United Silicon Carbide
Investments and Fair Value of Financial Instruments
Business Combination, Contingent Consideration, Liability, Noncurrent	0		0		0
Quoted Prices In Active Markets For Identical Assets (Level 1) | Fair Value, Recurring [Member] | Equity Securities
Investments and Fair Value of Financial Instruments
Marketable Securities	1,121,000		1,121,000		2,906,000
Quoted Prices In Active Markets For Identical Assets (Level 1) | Fair Value, Recurring [Member] | Mutual Fund
Investments and Fair Value of Financial Instruments
Deferred Compensation Plan Assets	37,687,000		37,687,000		39,356,000
Significant Other Observable Inputs (Level 2) | Fair Value, Recurring [Member] | United Silicon Carbide
Investments and Fair Value of Financial Instruments
Business Combination, Contingent Consideration, Liability, Noncurrent	0		0		0
Significant Other Observable Inputs (Level 2) | Fair Value, Recurring [Member] | Equity Securities
Investments and Fair Value of Financial Instruments
Marketable Securities	0		0		0
Significant Other Observable Inputs (Level 2) | Fair Value, Recurring [Member] | Mutual Fund
Investments and Fair Value of Financial Instruments
Deferred Compensation Plan Assets	0		0		0
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | United Silicon Carbide
Investments and Fair Value of Financial Instruments
Business Combination, Contingent Consideration, Liability, Noncurrent	(31,250,000)		(31,250,000)		(17,600,000)
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Equity Securities
Investments and Fair Value of Financial Instruments
Marketable Securities	0		0		0
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Mutual Fund
Investments and Fair Value of Financial Instruments
Deferred Compensation Plan Assets	$ 0		$ 0		$ 0

XML

Debt (Details) - USD ($)		3 Months Ended		9 Months Ended
	Apr. 06, 2022	Dec. 31, 2022	Jan. 01, 2022	Dec. 31, 2022	Jan. 01, 2022	Apr. 02, 2022	Dec. 14, 2021	Sep. 29, 2020	Jun. 11, 2020	Dec. 20, 2019	Sep. 30, 2019
Debt Instrument [Line Items]
Long-term debt		$ 2,047,743,000		$ 2,047,743,000		$ 2,047,098,000
Unamortized premium and issuance costs, net		(3,645,000)		(3,645,000)		(4,692,000)
Long-term Debt, Current Maturities		(451,000)		(451,000)		(791,000)
Interest Expense, Borrowings		18,100,000	$ 16,300,000		$ 48,700,000
Interest Costs Capitalized		1,000,000	900,000	3,000,000	2,800,000
Interest expense		17,066,000	$ 15,328,000	51,222,000	$ 45,934,000
4.375% senior notes due 2029
Debt Instrument [Line Items]
Debt Instrument, Face Amount		850,000,000		850,000,000		850,000,000			$ 300,000,000	$ 200,000,000	$ 350,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities		18,600,000		37,200,000
Debt Instrument, Interest Rate, Stated Percentage											4.375%
4.375% senior notes due 2029 | Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value		777,800,000		777,800,000		852,600,000
3.375% Senior Notes due 2031 [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount		700,000,000		700,000,000		700,000,000		$ 700,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities				0
Debt Instrument, Interest Rate, Stated Percentage								3.375%
3.375% Senior Notes due 2031 [Member] | Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value		572,300,000		572,300,000		638,600,000
Finance leases [Member]
Debt Instrument [Line Items]
Long-term debt		1,839,000		1,839,000		2,581,000
Senior Notes Due 2024 1.750%
Debt Instrument [Line Items]
Debt Instrument, Face Amount		500,000,000		500,000,000		500,000,000	$ 500,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities		4,400,000		8,800,000
Debt Instrument, Interest Rate, Stated Percentage							1.75%
Senior Notes Due 2024 1.750% | Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value		$ 459,800,000		459,800,000		$ 476,900,000
Credit Agreement | Federal Funds Rate
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.50%
Credit Agreement | Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1.00%
Credit Agreement | Maximum [Member] | Secured Overnight Financing Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1.25%
Credit Agreement | Maximum [Member] | Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.25%
Credit Agreement | Maximum [Member] | Loan Lending Commitment Arrangement Fees [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.20%
Credit Agreement | Minimum [Member] | Secured Overnight Financing Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1.00%
Credit Agreement | Minimum [Member] | Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.00%
Credit Agreement | Minimum [Member] | Loan Lending Commitment Arrangement Fees [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.15%
Term Loan [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity								$ 200,000,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity								$ 300,000,000
Proceeds from Lines of Credit				$ 0

XML

Stock Repurchases (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Dec. 31, 2022	Jan. 01, 2022	Nov. 02, 2022
Class of Stock [Line Items]
Stock Repurchased During Period, Shares	2.2	1.9	7.2	4.8
Stock Repurchased During Period, Value	$ 201,633	$ 302,020	$ 711,732	$ 825,393
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 1,855,000		$ 1,855,000
Document Period End Date			Dec. 31, 2022
November 2, 2022 Program
Class of Stock [Line Items]
Stock Repurchase Program, Authorized Amount					$ 2,000,000

XML

Commitments and Contingent Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022
Unrecorded Unconditional Purchase Obligation [Line Items]
Inventory Write-down	$ 4,000	$ 5,000	$ 11,000
Inventory, Firm Purchase Commitment, Loss	12,000	43,000	86,000
Asset Impairment Charges	8,000	$ 38,000	13,000
Other Liabilities, Current	149,466			$ 107,026
Other Liabilities, Noncurrent	$ 250,318			$ 233,629
Loss on Long-Term Purchase Commitment
Unrecorded Unconditional Purchase Obligation [Line Items]
Other Liabilities, Current			8,000
Other Liabilities, Noncurrent			$ 78,000

XML

Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Dec. 31, 2022	Jan. 01, 2022
Disaggregation of Revenue
Revenues	$ 743,281	$ 1,113,957	$ 2,936,696	$ 3,479,556
China
Disaggregation of Revenue
Revenues	124,799	273,582	630,012	1,227,782
Taiwan
Disaggregation of Revenue
Revenues	53,072	76,432	274,707	253,713
United States
Disaggregation of Revenue
Revenues	459,194	569,494	1,470,231	1,449,667
Europe
Disaggregation of Revenue
Revenues	34,214	58,360	171,056	183,539
Other Asia
Disaggregation of Revenue
Revenues	$ 72,002	$ 136,089	$ 390,690	$ 364,855

XML

Restructuring and Related Activities (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Dec. 31, 2022	Dec. 31, 2022	Apr. 02, 2022
Restructuring and Related Activities [Abstract]
Restructuring Charges		$ 19,580
Restructuring
Restructuring Charges		19,580
Payments for Restructuring		(2,989)
Restructuring Reserve	$ 16,591	16,591	$ 0
One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges		2,547
Restructuring
Restructuring Charges		2,547
Payments for Restructuring		(2,022)
Restructuring Reserve	525	525	0
Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges		17,033
Restructuring
Restructuring Charges		17,033
Payments for Restructuring		(967)
Restructuring Reserve	16,066	16,066	$ 0
fiscal year 2023
Restructuring and Related Activities [Abstract]
Restructuring Charges	27,385	32,479
Restructuring
Restructuring Charges	27,385	32,479
fiscal year 2023 | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	(623)	2,547
Restructuring
Restructuring Charges	(623)	2,547
fiscal year 2023 | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	12,899	12,899
Restructuring
Restructuring Charges	12,899	12,899
fiscal year 2023 | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	15,109	17,033
Restructuring
Restructuring Charges	15,109	17,033
Other operating expense | fiscal year 2023
Restructuring and Related Activities [Abstract]
Restructuring Charges	23,785	28,879
Restructuring
Restructuring Charges	23,785	28,879
Other operating expense | fiscal year 2023 | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	(623)	2,547
Restructuring
Restructuring Charges	(623)	2,547
Other operating expense | fiscal year 2023 | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	12,899	12,899
Restructuring
Restructuring Charges	12,899	12,899
Other operating expense | fiscal year 2023 | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	11,509	13,433
Restructuring
Restructuring Charges	11,509	13,433
Cost of goods sold | fiscal year 2023
Restructuring and Related Activities [Abstract]
Restructuring Charges	3,600	3,600
Restructuring
Restructuring Charges	3,600	3,600
Cost of goods sold | fiscal year 2023 | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	0	0
Restructuring
Restructuring Charges	0	0
Cost of goods sold | fiscal year 2023 | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	0	0
Restructuring
Restructuring Charges	0	0
Cost of goods sold | fiscal year 2023 | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	3,600	3,600
Restructuring
Restructuring Charges	$ 3,600	$ 3,600

XML

Operating Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Dec. 31, 2022	Jul. 02, 2022	Jan. 01, 2022	Dec. 31, 2022	Jan. 01, 2022
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Document Period End Date				Dec. 31, 2022
Summary of details of reportable segments
Revenues	$ 743,281		$ 1,113,957	$ 2,936,696	$ 3,479,556
Income from operations:
Operating income	8,729		296,010	372,150	955,472
Interest expense	17,066		15,328	51,222	45,934
Other income (expense), net	5,562		2,532	2,714	24,077
(Loss) income before income taxes	(2,775)		283,214	323,642	933,615
Stock-based compensation expense				(86,911)	(73,236)
Amortization of intangible assets				(99,476)	(112,523)
Charges associated with a long-term capacity reservation agreement (2)		$ 110,000
Repayments of Long-Term Debt				0	(197,500)
Operating Segments | HPA
Summary of details of reportable segments
Revenues	155,011		181,876	594,094	496,842
Income from operations:
Operating income	29,836		56,951	181,102	140,953
Operating Segments | CSG
Summary of details of reportable segments
Revenues	96,810		157,578	392,454	525,190
Income from operations:
Operating income	(31,145)		21,109	(29,926)	77,287
Operating Segments | ACG
Summary of details of reportable segments
Revenues	491,460		774,503	1,950,148	2,457,524
Income from operations:
Operating income	99,862		293,948	569,439	956,215
All other
Income from operations:
Operating income	(89,824)		(75,998)	(348,465)	(218,983)
Stock-based compensation expense	(19,708)		(19,307)	(86,911)	(73,236)
Amortization of intangible assets	(32,844)		(38,443)	(99,283)	(112,243)
Restructuring and disposal costs				(32,479)	0
Acquisition and integration related costs	(6,296)		(6,552)	(21,246)	(16,585)
Charges associated with a long-term capacity reservation agreement (2)	0		0	110,000	0
Other	$ (3,591)		(11,696)	$ 1,454	(16,919)
Repayments of Long-Term Debt			$ 0		$ (27,385)

XML

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Dec. 31, 2022	Jan. 01, 2022
Income Tax Disclosure [Abstract]
Income Tax Expense (Benefit)	$ 13,156	$ 66,951	$ 82,074	$ 112,537
Effective tax rate	(474.10%)	23.60%	25.40%	12.10%
Discrete tax expense (benefit)	$ 2,200	$ 42,500	$ 10,400	$ 12,000

XML

Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Dec. 31, 2022	Jan. 01, 2022
Earnings Per Share [Abstract]
Document Period End Date			Dec. 31, 2022
Numerator:
Numerator for basic and diluted net income (loss) per share — net income (loss) available to common stockholders	$ (15,931)	$ 216,263	$ 241,568	$ 821,078
EPS Line Items
Denominator for basic net income (loss) per share — weighted average shares	100,943	109,687	103,039	110,966
Stock-based awards	0	1,123	773	1,449
Denominator for diluted net income (loss) per share — adjusted weighted average shares and assumed conversions	100,943	110,810	103,812	112,415
Basic net income (loss) per share (in dollars per share)	$ (0.16)	$ 1.97	$ 2.34	$ 7.40
Diluted net income (loss) per share (in dollars per share)	$ (0.16)	$ 1.95	$ 2.33	$ 7.30
Antidilutive shares excluded from the computation of diluted shares outstanding	2,000		900